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INTRODUCTION 
  
 Siddha system of medicine is a potent and unique indigenous system of medicine, 
which deals with the disease of men efficiently with the knowledge of both subtle and 
also the gross material body. 
 The origin of the siddha system dates back BC 10000 – BC 4000, according to 
Thiru. T. V. Sambasivampillai  siddha medical dictionary. The word siddha comes from 
the word siddhi.Siddhi means knowledge or wisdom. The ultimate aim of siddha is to 
attained perfection or heavenly bliss. 
 Siddha system of medicine classifies diseases into 4448 types. According to this 
system of medicines, the human body is made up on three humors – Vali, Azhal, Iyyam 
in normal healthy condition ratio between them being 1:½ : ¼.When the normal ratio of  
Sthese humors – Vali, Azhal, Iyyam is disturbed, disease will occur. The factors which 
affect this equilibrium are environment, climatic conditions, diet and abnormal physical 
activities etc. 
 As per “Varma odivu murivu maruthuvam” ,mootu kayangal is classified into 3 
types. One such type is Muzhangal mootu savvu kayangal.  Muzhangal mootu savvu 
kayangal has a symptoms of pain and swelling present in joints, difficulty in flexion and 
extension. 
 The human physical body comprises many joints, which extends small to large in 
nature for the purpose of fine to vast movements. Some joints is very important for 
weight bearing and locomotion. A joint encompasses bony parts, ligaments, tendons and 
synovial membranes and fluids. The knee joint is an imperative for weight bearing and 
locomotion and also take the necessary parts in sports activity.Ligament injury- knee 
joint is an annoying and painful condition that limits the functions of the joint. There is a 
pain and tenderness in the knee joints during standing and walking. So, this condition 
Muzhangal mootu savvu kayangal may be correlated to Ligament injury-knee joint. 
 A relatively high incidence of ligamentous disruptions has been noted in obese 
and loose joined people, particularly from exposure to athletic activity. Motor vehicular 
accidents especially involving motorcycles, are common causes of knee ligament 
disruptions.Popping sensation felt or heard at the time of injury signifies ligamentous 
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injury. Patient may present with pain, swelling of the knee could be either due to 
hemarthrosis or traumatic synovitis, history of locking or instability in the knee joint. 
 Sports-related injury knee injuries occur commonly in athletes. In 2016 survey, 
Anterior cruciate ligament injury was the most common injury and was noted in 86.5% 
of knee injuries (n=314: complete ACL tear- 287 and partial ACL tear- 27). Meniscal 
injury was the second most common knee injry seen in 78.24% of the knee injuries. 
Collateral ligament injuries were noted in 133 knees with MCL injury seen in 25.62% of 
the knees (n=93) and LCL injuries seen in 11.01% (n=40). Posterior ligament injuries 
were the least observed injuries accounting for 2.76% of the injuries (n= 10).  
 In modern system of medicine, only recourse for the ligament injury is surgery. 
Siddha system has good ailments to take ligament injuries especially through external 
therapy and Varmam therapy. 
Now a days, considerably more number of patients reporting daily for the treatment 
for Muzhangal mootu savvu kayangal (Ligament injury – knee joint) in Ayothidoss 
Pandithar Hospital,  National Institute of Siddha. The ingredients of Vithu rasa mezhugu 
has pharmacological activities like Analgesic and Anti-inflammatory activities. Hence 
the author has chosen this disease with the trial drug “Vithu Rasa Mezhugu” (Internal) 
and “MurivuEnnai” (External).  
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                                              AIM AND OBJECTIVE 
AIM 
To evaluate the therapeutic efficacy of siddha drugsVithu Rasa 
Mezhugu(Internal) and Murivu ennai (External) in reducing the pain and restricted 
movements in the treatment of Muzhangal mootu savvu kayangal (Ligament injury-knee 
joint) with and without varmam therapy through clinical study. 
PRIMARY OBJECTIVE:  
To evaluate the therapeutic efficacy of siddha drugsVithu Rasa 
Mezhugu(Internal) and Murivu ennai (External) in reducing the pain and restricted 
movements in the treatment of Muzhangal mootu savvu kayangal (Ligament injury-knee 
joint) with and without varmam through clinical study. 
SECONDARY OBJECTIVE:   
1) To study the pattern of Naadi 
2) To study the pattern of Neikuri 
3) To analyze the distribution of Udal thathukal 
4) Biochemical analysis 
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SIDDHA ASPECT 
MUZHANGAL MOOTU SAVVU KAYANGAL 
 In Siddha literature Muzhangal mootu savvu kayangal(MMSK) described under 
Vaatha diseases. The Mootu kayangal is the general term that includes all kinds injuries 
to the joint. 
Description of the nomenclature 
Muzhangal mootu savvu kayangal  =   Muzhangal mootu + savvu +                      
     kayangal 
Muzhangal mootu =  Knee joint 
Savvu =  Ligaments 
Kayangal  =  Injuries 
 Thejoint is initially affected by vitiated vaatham, Pitham and Kabam accompany 
later. 
TYPES OF MOOTU KAYANGAL: 
 There are three types of mootu kayangal which are mentioned in the textbook 
“VARMA ODIVU MURIVU MARAUTHUVAM”. MMSK is one among 3 types of 
Mootu kayangal. The 3 types are mentioned below 
1. Savvu kayangal(Injuries to ligaments) 
2. Mooturai kayangal(Injuries to synovium) 
3. Naanuraipai kayangal(Injuries to bursa) 
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Å¡¾ò¾¢ý þÕôÀ¢¼õ 
“¿¡¦ÁýÈ Å¡¾òÐì ¸¢ÕôÀ¢¼§Á §¸Ç¡ö 
¿¡ÊìÌì ¸£¦ÆýÚ ¿Å¢ÄÄ¡Ìõ” 
Å¡¾õ Å¡ØÁ¢¼õ: 
«À¡Éõ, ÁÄõ, þ¼¸¨Ä, ¯ó¾¢Â¢ý ¸£ú ãÄõ, ¸¡Áì¦¸¡Ê, þÎôÒ 
±ÖõÒ, §¾¡ø, ¿ÃõÒìÜð¼õ, ¸£ø¸û, ÁÂ¢÷ì¸¡ø¸û, °ý. 
 Muzhangal mootu savvu kayangal is a clinical condition which occurs 
when ligaments around the knee joint is either stretched, partially torn or completely 
torn. Joints (¸£ø¸û) are one of the places where “Vaatham” resides.  
AETIOLOGY: 
1. DIET: 
Vaatha disease is caused due to the following reasons:  
According to the text ‘Sababathi Kaiyedu’ 
 
“ÅÇ¢ ¾Õ ¸¡ö¸¢ÆíÌ Å¨ÃÅ¢Ä¡ ¾Á¢Äø §¸¡¨Æ 
ÒÇ¢ ¾Â¢÷ §À¡ýÁ¢ÌìÌ Ó¨ÈÂ¢Ä¡ ×ñÊ §¸¡¼ø 
ÌÇ¢÷¾Õ ÅÇ¢Â¢ü §È¸í ÌÉ¢ôÒÈ ×ÄÅø ¦ÀñÊ÷ 
ÌÇ¢¾Õ ÁÂì¸õ ¦Àü§È¡÷ ¸Ê¦ºÂø ¸ÕÅ¢Â¡Áø." 
 Excessive intake of tubers  
 Excessive intake of chill foods just like the curd. 
 Wandering in chill air in evening time 
 Getting drenched in rain 
 Living in hilly region 
 Excessive sexual indulgence. 
 Heredity. 
 Excessive intake of bitter, astringent pungent.  
 intake of vaatha food substance like varagu, thinai   
 Altered sleep pattern also contribute to Vaatha disease. 
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2. HABITS: 
“¾¡¦ÉýÈ ¨¸ô¦À¡Î ÐÅ÷ôÒÅ÷ôÒ 
º¡¾¸Á¡ö Á¢ïÍ¸¢Öõ º¨Áò¾ «ýÉõ 
¬¦ÉýÈ ¬È¢ÉÐ Òº¢ò¾¡Öõ 
¬¸¡ºò §¾üÈ ¿£÷ ÌÊò¾Ä¡Öõ 
Â¡¦ÉýÈ À¸ÖÈì¸õ þÃ¡Å¢Æ¢ôÒô 
ÀðÊÉ¢§Â Á¢¸×Ú¾ø À¡Ã¦Áö¾ø 
§¾¦ÉýÈ ¦Á¡Æ¢Â¡÷ §Áø º¢ó¨¾Â¡¾ø 
º£ì¸¢ÃÁ¡ö Å¡¾ÁÐ ¦ºÉ¢ìÌó¾¡§É”     
    -  ä¸¢ÓÉ¢ ¨Åò¾¢Â º¢ó¾¡Á½¢ 
 Intake of food rich in bitter ,sour and pungent in taste 
 Intake of cold and old foods 
 Sleep in day time.  
 Lack of sleep 
 Excessive starvation 
 Weight lifting 
 Increased sexual indulgence 
 These are the factors  that disturbs &  increase vaatham in our body 
3. INVOLVEMENT OF MUKKUTRAM IE VAATHAM, PITHAM AND 
KABAM: 
 Viyanan and samanan are affected in Vaatham. Due to pain present in knee 
joints. 
 In Pitham, Sathaga pitham is affected. Due to difficulty in performing daily 
activities. 
 Santhigam is affected in Iyyam. Due to pain and crepitation present in knee 
joints. 
6. CHARACTERISTIC FEATURES OF VAATHAM: 
“Å¡¾ÁÐ ¸¾¢ò¾ §À¡Ð Å¡Ô¦ÁØõÒí ¸ñË÷ 
 Å¡¾§Á ¸¾¢ò¾§À¡Ð Å¡Ô×  Åó¾¢Îï ºó¿¢§¾¡¼õ 
 Å¡¾§Á ¸¾¢ò¾§À¡Ð Åó¾¢Îõ Å¢Â¡¾¢ §ÁÖõ 
 Å¡¾§Á ¸¾¢ò¾§À¡Ð ÅøÖ¼ø ¦ÁÄ¢óÐ ¦¸¡øÖõ” 
      - «¸ò¾¢Â÷ º¢¸¢îº¡Ãò¾¢É ¾£Àõ 
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 When the vaatham is increased from their normal level causes sanni and weight 
loss leads to death. 
“Å¡¾ Å£Ú «ýÉÁ¢Ãí¸¡Ð ¸ÌôÒñ¼¡õ Åñ½Óñ¼¡õ 
§Á¡Ð¸ðÌ §Ã¡¸õ ÍÃÓñ¼¡ Á¢ÕÁÖÁ¡ ÓÈí¸¡¦¾ýÚõ 
µ¾Ã¢Â Å¡¾ÁÉÄ¡Ì ¿Îì¸Óñ¼¡õ ¦À¡Õû ¸ÇÂ÷ó¾ 
¾£¾É§Å ¿ÃõÀ¢òÐ ºóÐ¸û §¾¡Úí¸¼ìÌó ¾¢ÉÓó¾¡§É” 
      - §¾¨ÃÂ÷ Å¡¸¼õ 
 When the Vaatha kuttram aggravates it will produce the following signs and 
symptoms: 
 loss of appetite 
 excruciating pain 
 fever 
 Defect in the micturation and defecation 
 loss of sleep 
 shivering of the body 
 nervous weakness 
 Joint pain. 
SITES OF VAATHAM 
“¦¿Ç¢ó¾¢ð¼ Å¡¾Á¼¡ ¿ò¨¾ô ÀüÈ¢ 
      ¿¢¨Èó¾¢¨¼Âî §º÷óÐó¾¢ì ¸£§Æ ¿¢ýÚ 
ÌÇ¢ó¾¢ð¼ ãÄÁà¦¼ØóÐ ¸¡Áì 
¦¸¡ÊÂ¢¨¼¨Âô ÀüÈ¢¦ÂØí Ì½ò¾ôÀ¡§Ã 
 Ì½Á¡É ¦ÅØõ¨À¦Áü ¦È¡ì¨¸ ¿¡Ê 
¿¢½Á¡É ¦À¡Õó¾¢¼Óõ §Ã¡Áì ¸¡Öõ 
¿¢¨ÈÅ¡¸¢ Á¡í¸¢º¦Áø Ä¡õÀÃóÐ 
¸¡ø¸ðÊ Å¡¾¦ÁíÌí ¸ÄìÌó ¾¡§É”  
      - ¨Åò¾¢Â º¾¸õ 
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 According to vaithiya sathagam, vaatham dwells in the following places: 
Umbilicus, rectum, faecal matters, abdomen, anus, bones, hipjoints, skin, navel 
plexus,Joints, Hair follicles and muscles. 
PROPERTIES OF VAATHAM :      
Vaatham helps the following function in our body 
 It is the main vital humour for the function of 7 UDALKATTUGAL 
 Helps to do all activities 
 It stimulate and accelerate 5 PULANGAL 
Natural properties of Vaatham: [Ref: Noi Nadal part-1] 
1. Functioning of the “Seven Udal Kattukal” uniformly 
2. Protection and strengthening of the five sensory organs (Imporigal) 
3. Giving briskness 
4. Expiration and Inspiration 
5. Regulation of the “Fourteen Physiological Reflexes” (Vegam) 
6. Functioning of the mind, thoughts and body 
DIAGNOSIS IN SIDDHA: 
 In siddha system of medicine diagnosis of a disease is very important. 
Piniyari muraigal (Method of Diagnosis) is based upon three main principles, 
1. Poriyal Arithal (Examination of Sensory Organs) 
2. Pulanal Arithal (Examination of Sensory Functions) 
3. Vinaathal (interrogation) 
1. PORIYAL ARITHAL (Examination of Sensory Organs) : 
PORI – SENSE ORGANS 
 “Poriyal arithal” means examining the “Pori” of the patient by the “Pori” of the 
physician for proper diagnosis. 
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Pori is considered as the “Five sense organs” of perception namely, 
1. Mei (Skin) 
2. Vai (Tongue) 
3. Kan (Eye) 
4. Mookku (Nose) 
5. Sevi (Ear) 
2. PULANAL ARITHAL (Examination of Sensory Functions): 
PULAN – SENSE 
 Pulanal arithal means examining the “Pulan” of the patient by the “Pulan” of 
Physician. 
Pulan are five senses. They are, 
1. Smell  
2. Taste 
3. Vision 
4. Sensation of touch 
5. Hearing 
3. VINAATHAL (Interrogation): 
 Vinaathal is gathering information regarding the history of disease, its clinical 
features, major complaints, duration of illness etc., from the patient or his/her close 
relatives useful when the patient is not in a position to speak or in the case of a child. 
ENVAGAI THERVUGAL (Eights Folds of Examination): 
 It is a unique method of diagnosis in Siddha system of medicine. They are 
clearlyexplained by Siddhar Theraiyar; 
“¿¡Ê ŠÀÃ¢ºõ ¿¡ ¿¢Èõ ¦Á¡Æ¢ Å¢Æ¢ 
ÁÄõ ãò¾¢ÃÁ¢¨Å ÁÕòÐÅÃ¡Ô¾õ” 
 - §¾¨ÃÂ÷ 
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1. Naadi (Pulse): 
“¾¢Õò¾Á¡õ Å¡¾ò§¾¡§¼ ¾£í§¸¡Î À¢ò¾õ §ºÃ¢ü 
¦À¡ÕòÐ¸û §¾¡Úõ ¦¿¡óÐ §À¡¾§Å À¢ÊìÌõ” 
       - §¿¡Â¢ý º¡Ãõ 
 
“Å¡ðÊÎõ §ºòÐÁò¾¢ø Åó¾¢Îõ Å¡¾Á¡¸¢ø 
¿¡ðÊÂ ¸¡ø¸û §À¡Ä ¿Ãõ¦ÀøÄ¡õ ÅÄ¢òÐ ¿¢üÌõ” 
       - «¸ò¾¢Â÷ ¿¡Ê 
 
“¦º¡øÄ¢Â ³Âò§¾¡§¼ À¢ò¾Óí ÜÊü È¡É¡ø 
ºÄÄ¢Âõ §À¡Äì ÌòÐõ ¨Áó¾§É ±ÖõÒõ §¾¡Öõ” 
       - ¸¡Å¢Â ¿¡Ê 
2. When Pitham gets vitiation it accompany with Vaatham and causes pain in every 
joints  
3. When Kabam and Vaatham are vitiated pain occurs in the nerves and lower 
extremities. 
4. When Pitham vitiated with Kabam it results in stabbing pain in bones and joints. 
 In MMSK the following Naadi can be seen commonly:Vaathapitham, 
Vaathakabam, Pithavaatham, Pithakabam, Kabavaatham. 
2. Sparism (Sensation to touch): 
In MMSK  warmth noticed over the affected joint. 
3. Naa (Tongue): 
 In MMSK no abnormality is seen in Naa. 
4. Niram (Colour): 
 In MMSK no abnormality is seen in Niram. The skin complexion is used to 
diagnose the body constitution of the patient. 
5. Mozhi (Voice) 
 It constitutes high, low-pitched voice, nasal speech, hoarseness of voice slurring 
and incoherent speech etc. In MMSK no abnormatlities are seen normally. 
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6. Vizhi (Eyes): 
 Both motor and sensory disturbance of eye are noticed. Redness of eyes, 
paleness, excessive lacrimation, swelling, corneal ulcers, sunken eyes may be noted for.  
In MMSK no abnormatlities are seen normally. In anaemic patients pale conjunctiva may 
be noted. 
7. Malam (Faeces): 
 Vaatha type: Black coloured stools with constipation. 
 Pitha type: Loose stools with yellowish red colour 
 Kaba type: White coloured stools with mucous 
 Thontha type: Stools possess some of the features of two humours. 
 In MMSK constipation was reported in some cases. 
8. Moothiram: 
 Neerkuri and Neikuri (Oil on urine sign) are special diagnostic methods regarding 
urine (Moothiram). 
A.NEERKURI (Physical examination of urine): 
“«ÕóÐ Á¡È¢Ã¾Óõ «Å¢§Ã¡¾Á¾¡ö 
«¸Ä «Ä÷¾ø «¸¡Äçý ¾Å¢÷ó¾Æü 
ÌüÈÇ ÅÕó¾¢ ¯Èí¸¢ ¨Å¨¸¨È 
¬Êì ¸Äºò ¾¡Å¢§Â ¸¡Ð¦Àö 
§¾¡Õ ÓÜ÷ò¾ì ¸ÉÄì ÌðÀÎ ¿£Ã¢ý 
¿¢ÈìÌÈ¢ ¦¿öìÌÈ¢ ¿¢ÕÁ¢ò¾ø ¸¼§É” 
     - º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ 
 Prior to the day of urine examination the patient is instructed to take a balanced 
diet and quantities of food must be proportionate to his routine intake. The patient should 
have no sound sleep. After waking up in the morning, the first urine voided is collected 
in a clear wide mouthed glass bowel and is subjected to analysis of “Neerkkuri and 
Neikkuri” within 1½ hour. 
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“Åó¾ ¿£÷ì¸Ã¢ ±¨¼ Ñ¨Ã ±ïº¦Äý 
¨Èó¾¢Â ÖÇ¨Å Â¨ÈÌÐ Ó¨È¦Â” 
- º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ 
 
Voided urine has the following characters 
1. Niram   - Colour 
2. Edai   - Specific Gravity 
3. Manam  - Smell 
4. Nurai   - Frothy nature 
5. Enjal   - Deposits 
 Apart from these, the frequency of urination, abnormal constituents, such as 
sugar, protein, presence of blood, pus, also to be found out In MMSK patient straw 
coloured urine was noticed. 
B. NEIKKURI (Oil on urine sign): 
The process of dropped gingely oil indication 
“¿¢ÈìÌÈ¢ì Ì¨Ãò¾ ¿¢ÕÁ½ ¿£Ã¢ü 
º¢Èì¸ ¦Åñ¦½ö§Â¡÷ º¢ÚÐÇ¢ ¿ÎÅ¢Îò 
 
É¢ýÈ¾¢Å¨Ä §À¡õ ¦¿È¢Å¢Æ¢ÂÈ¢×õ 
¦ºýÈÐ Ò¸Öï ¦ºö¾¢¨Â Ô½§Ã” 
-§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø ¾¢ÃðÎ-
À¡¸õ 1 
 The collected specimen was examined by the following method. The collected 
urine specimen is kept in a glass bowel and observed under direct sunlight without 
shaking the vessel. Then drip one drop of gingely oil and observe the spreading pattern 
and concludes as follows, 
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“«Ã¦ÅÉ ¿£ñÊÉ «ì§¾ Å¡¾õ 
¬Æ¢§À¡ü ÀÃÅ¢ý «ì§¾ À¢ò¾õ 
Óò¦¾¡òÐ ¿¢ü¸¢ý ¦Á¡Æ¢Å¦¾ý ¸À§Á 
«ÃÅ¢ø ¬Æ¢Ôõ ¬Æ¢Â¢ø «Ã×õ 
«ÃÅ¢ý ÓòÐõ ¬Æ¢Â¢ø ÓòÐõ” 
-§¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø ¾¢ÃðÎ-À¡¸õ 1 
 When the oil drops lengthens like a snake it indicates „Vaatha Neer‟ 
 When the oil drops spreads like a ring it indicates „Pitha Neer‟ 
 When the oil drops remains that of pearl it indicates‟ Kaba Neer‟ 
UDAL KATTUGAL (Body Constituents): 
 In MMSK, Saaram, Kozhuppu, Moolai and Enbu thathukkal are commonly 
affected. 
1. Saaram : Weakness, pain in knee joints 
2. Kozhuppu : Morning stiffness occurs in affected knee joints 
3. Enbu  : Pain occurring in affected knee joints& crepitations 
4. Moolai  : Inflammation, swelling etc 
MUKKUTRA VERUPAADU (PATHOGENESIS) 
 Human body is influenced by Mukkutrams ie Vaatham, Pitham and Kabam. They 
are responsible for normal physiological conditions of the body.  
VAATHAM (Bio Energy of Movements): 
 Vaatham is mainly responsible for proper loco-motor functions.Bones and joints 
are considered to be the main location of vaatham.In MMSK the vaatha kutram is mainly 
affected followed by Pitham andKabam. This produces the following signs and 
symptoms, 
 Vitiated viyanan leads to pain and difficulty in movements. Vitiated abanan leads 
to constipation. 
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 Inflammatory changes of the joints, redness and warmth are developed due to 
vitiated pitham.  
 Sathaga pitham gets affected hindering the loco motor functions  
 Along with vaatham, kabam is also vitiated, santhikam is affected and this leads 
to Abnormality in joint movements 
 
1. In MMSK Abanan is affected and so constipation is produced. 
2. Viyanan is affected it renders difficulty in movements of the knee joints. 
3. Samanan is also affected because disturbed state of other Vaayus. 
PITHAM (Bio Energy of Fire): 
 In MMSK, Sathaga Pitham affected and produces difficulty in walking, climbing 
upstairs, squatting and sitting postures. 
KABAM (Bio Energy of Water): 
 Kaba kutram stabilizes and maintains the movements of the joints and gives 
lubrications to all movements. 
 In MMSK  Santhigam is affected and produce difficulty in movements of the knee 
joints. 
NOI KANIPPU VIVAATHAM (DIFFERENTIAL DIAGNOSIS): 
Muzhangal mootu savvu kayangal is differentiated from the followings diseases, 
1. AZHAL KEEL VAAYU:  It is characterized by pain in the joints associated 
with effusions of joint fluid and swelling, warmth, tenderness and restricted joint 
movements, especially in knee joint asymmetrically, morning stiffness, crackling 
sound present when the joint is moved etc. 
LINE OF TREATMENT: 
 In Siddha system the main aim of the treatment is to cure Udarpini (due to 
Mukkuttram) and Manapini (due to changes in Mukkunam). Treatment is not only for 
perfect healing but also for the prevention and rejuvenation. 
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 It is essential to know the disease, the aetiology, the nature of the patient, severity 
of the illness, the seasons and the time of occurrence must be observed clearly. 
Line of treatment is as follows: 
1. Neekkam (Treatment) 
2. Niraivu (Rejuvenation) 
3. Kaapu (Prevention) 
1) NEEKKAM (Treatment in Siddha): 
 Siddha system of Medicine is based on Mukkutra Theory. Hence the treatment is 
mainly aimed to bring the vitiation of three humours to equilibrium state and thereby 
restoring the physiological condition of the seven Thathus. 
 The three Humours organise, regularise and integrate the body structure and their 
functions. They are always kept in a state of balance by thought, word, deed and food. 
Any imbalance will lead to disease. The imbalanced humours are balanced by 
administrating purgatives or emetics or application of Anjanam (application on eyes) and 
followed by the appropriate systemic therapy by giving drugs.  
 The trial drugs Vithu rasa mezhugu – 65mg twice a day given with palm jaggery 
after food. Murivuennai was applied externally. 
2) NIRAIVU (Rejuvenation): 
 Physical, psychological, social and economic rehabilitation and reassurance of 
individuals is known as Niraivu. The word literally means the power of securing the 
body from the effect ofage. According to Siddhars science rejuvenation does not 
necessarily mean restoring the oldto youth for it may simply mean the maintenance of 
youth without reaching the old age.So rejuvenation is a means for prolonging life & 
forms a part of immortality. 
       - T.V. Sambasivam pillai dict 
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3. KAPPU (PREVENTION): 
 The prevention methods for MMSK are as follows: 
 Control the body weight by diet and exercise. 
 Modify the nature of work which gives stress to a particular joint. e.g. - Avoid 
prolonged standing and long distance walking. 
 Avoid excessive intake of sour, astringent and bitter tasted foods. 
4) DIETARY RESTRICTIONS:  
 In siddha system of medicine the importance of dietary habits also emphasiszed 
for the diseases management and prevention. This line is well understood in these verses, 
"¯½§Å ÁÕóÐ ÁÕó§¾ ¯½×" 
 
"ÁÕó¦¾É §Åñ¼¡Å¡õ Â¡ì¨¸ìÌ «Õó¾¢ÂÐ 
«üÈÐ §À¡üÈ¢ ¯½¢ý" 
-¾¢ÕìÌÈû 
 
 In diseased condition diet restrictions or paththiyam are strictly followed to 
increase the effectiveness of medicine, and to reducing the severity of diseases. This is 
given in the following verse, 
"Àò¾¢Âò¾¢É¡§Ä ÀÄý ¯ñ¼¡Ìõ ÁÕóÐ 
Àò¾¢Âí¸û §À¡É¡ø ÀÄý§À¡Ìõ-Àò¾¢Âò¾¢ø 
Àò¾¢Â§Á ¦ÅüÈ¢¾Õõ ÀñÊ¾÷ìÌ ¬¾Ä¢É¡ø 
Àò¾¢Â§Á ¯ò¾¢¦ÂýÚ À¡÷" 
- §¾¨ÃÂ÷ ¦ÅñÀ¡ 
 
þîº¡ Àò¾¢Âò¾¢ø ¿£ìÌõ ¦À¡Õð¸û: 
"¸ÎÌ ¿üÈ¢Äò ¦¾ñ¨½ö ÜúÀ¡ñ¼í¸û ¸¼¨Ä 
ÅÕÅ¾¡¸¢Â ¦¾íÌÁ¡ ÅÕì¨¸ ¿ü¸¡Âõ 
ÁÊÅ¢Ä¡¾ ¦ÅûÙûÇ¢¦¸¡û Ò¨¸Â¢¨Ä ÁÐ¦Àñ 
þ¼Ú À¡¸§Ä¡ ¼¸ò¾¢ ¿£ì¸¢¼Ä¢îº¡ Àò¾¢Âõ" 
- º¢ò¾ ÁÕòÐÅ¡í¸î ÍÕì¸õ 
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¸ÎÌ, ±û¦¿ö, ¸øÂ¡½âº½¢ì¸¡ö, ¸û, ¸¼¨Ä, §¾í¸¡ö, Á¡í¸¡ö, 
ÀÄ¡, ¸¡Âõ, ¯ûÇ¢âñÎ, ¦¸¡û, Ò¨¸Â¢¨Ä, ¦Àñ¸û §º÷ì¨¸, À¡¸ø, 
«¸ò¾¢ þ¨Å¸¨Ç þîº¡ Àò¾¢Âò¾¢ø ¿£ì¸§ÅñÎõ. 
 
 "ÒÇ¢ÐÅ÷ Å¢ïÍõ ¸È¢Â¡ø âÃ¢ìÌõ Å¡¾õ" 
- §¿¡ö ¿¡¼ø §¿¡ö Ó¾ø ¿¡¼ø ¾¢ÃðÎ 
 
ÁÕòÐÅ «È¢×¨Ã: 
 
 ÒÇ¢ôÒ, ÐÅ÷ôÒ Í¨ÅÔûÇ ¯½× Å¨¸¸¨Ç ¿£ì¸ §ÅñÎõ 
 ®ÃÁ¢øÄ¡ò ¾¨ÃÂ¢Öõ, ÀÎì¨¸Â¢Öõ ÀÎò¾ø §ÅñÎõ. 
 ÌÇ¢÷ ¸¡üÚ ÀÎõÀÊÂ¡É þ¼ò¾¢ø þÕôÀ¨¾ò ¾Å¢÷ì¸×õ 
 ¯¼ø «¾¢¸ ±¨¼ þÕôÀ¢ý ±¨¼¨Âì Ì¨Èì¸ §ÅñÎõ. 
 «¾¢¸ àÃõ ¿¼ò¾ø, «¾¢¸ §¿Ãõ ¿¢üÈø ¾Å¢÷ì¸×õ. 
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MODERN ASPECTS 
ANATOMY OF JOINTS: 
 Joints can be classified as synovial, fibrous, or combination joints, based on the 
presence or absence of a synovial membrane and the amount of motion that occurs in the 
joint. Normal synovial joints allow a significant amount of motion along their extremely 
smooth articular surface. The joints are composed of the following: 
 
 Articular cartilage 
 Subchondral bone 
 Synovial membrane 
 Synovial fluid 
 Joint capsule. 
 The normal articular surface of synovial joints consists of articular cartilage 
(Composed of chondrocytes) surrounded by an extracellular matrix that includes various 
macromolecules, most importantly proteoglycans and collagen. The cartilage protects the 
underlying subchondral bone by distributing large loads, maintaining low contact 
stresses, and reducing friction at the joint. 
 
 Synovial fluid is formed through a serum ultra filtration process by cells that 
form the synovial membrane (synoviocytes). Synovial cells also manufacture the major 
protein component of synovial fluid, hyaluronic acid (also known as hyaluronate). 
Synovial fluid supplies nutrients to the avascular articular cartilage; it also provides the 
viscosity needed to absorb shock from slow movements, as well as the elasticity required 
to absorb shock from rapid movements. 
 
ANATOMY OF THE KNEE JOINT 
Introduction: 
 The knee joint is the largest joint in the body, consisting of four bones and an 
extensive network of ligaments and muscles. Injuries to the knee joint are amongst the 
most common in sporting activities and understanding the anatomy of the joint is 
fundamental in understanding any subsequent pathology. 
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Bones of the knee joint: 
 The knee is made up of four main bones. The femur (thigh bone), the tibia (shin 
bone), fibula (outer shin bone) and patella (kneecap). The main movements of the knee 
joint occur between the femur, patella and tibia. Each are covered in articular cartilage 
which is an extremely hard, smooth substance designed to decrease the frictional forces 
as movements occurs between the bones. The patella lies in an indentation at the lower 
end of the femur known as the inter-condylar groove. At the outer surface of the tibia lies 
the fibula, a long thin bone that travels right down to the ankle joint. 
 
The capsule: 
 The knee joint capsule is a thick ligamentous structure that surrounds the entire 
knee. Inside this capsule is a specialized membrane known as the synovial membrane 
which provides nourishment to all the surrounding structures. Other structures include 
the infrapatellar fat pad and bursa which function as cushions to exterior forces on the 
knee. The capsule itself is strengthened by the surrounding ligaments. 
Ligaments of the knee joint: 
 The stability of the knee owes greatly to the presence of its ligaments. Each has a 
particular function in helping to maintain optimal knee stability in a variety of different 
positions. 
Menisci (knee cartilage): 
 Each knee joints has two crescent shaped cartilage menisci. These lie on the 
medial and lateral edges of the upper surface of the tibia bone. They are essential 
components, acting as shock absorbers for the knee as well as allowing for correct 
weight distribution between the tibia and the femur. 
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LIGAMENTS AND MENISCI OF KNEE JOINTS 
 
Muscle groups surrounding the knee joint: 
 The two main muscle groups of the knee joint are the quadriceps and the 
hamstrings. Both play a vital role in moving and stabilizing the knee joint. 
Quadriceps muscle: 
 The quadriceps muscle group is made up of four different individual muscles 
which join together forming the quadriceps tendon. This thick tendon connects the 
muscle to the patella which in turn connects to the tibia via the patellar tendon. 
Contraction of the quadriceps, pull the patella upwards and leads to knee extension. 
Hamstrings muscle: 
 The Hamstrings muscle function in flexing the knee joint as well as providing 
stability on either side of the joint line. 
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MUSCLES AROUND THE KNEE JOINT 
AP-VIEW 
 
 
LATERAL VIEW 
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KNEE JOINT-LIGAMENT INJURY: 
INTRODUCTION: 
   
  
 With modern high-speed vehicular trauma and increasing athletic participation, 
both competitive recreational, traumatic lesions of the ligaments about the knee are 
becoming increasingly more common. Knee stability depends on numerous factors, 
including the mechanical axes of the joint, the bony contours, the intraarticular 
stabilizers (the menisci and cruciate ligaments), and extraarticular stabilizers (the 
synovium, capsular ligaments, collateral ligaments, and musculotendinous units). 
 The goal of treatment of traumatic lesions of the ligaments is restoration of the 
anatomy and stability to as near preinjury status as possible. Failure to accomplish this 
results in ajoint increasingly susceptible to more damage from the normal living and 
trivial trauma. Also, failure to restore normal knee stability exposes other structures such 
as the menisci, the cruciate ligaments, and the joint surfaces to additional injury as well 
as markedly reducing the functional capabilities and activities of the individual. The 
result often is severe degenerative arthritis. 
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EPEDEMIOLOGY: 
 With an incidence of about 30 cases of ACL injury per 100 000 people  per year, 
any district general hospital should have a sufficient throughput to provide a surgeon 
with enough patients to maintain and improve his/her operative skills. A hospital with a 
catchment area of 400000 population population will have about two fresh ACL injuries 
a week presenting through their casualty department. 
Age and sex related prevalence: 
 In 1995, female racers were 2.3 times more likely to have sustained a knee injury 
than male racers. More impressively, one in five female alpine racers (22%) reported an 
ACL distruption, and female were 3.1 times more to sustain an ACL injury in 
comparison to their male counterparts. Of the athletes who had surgery to reconstruct 
their ACL, approximately one-third (36%) required subsequent surgery to the same knee. 
One in five (22%) ACL reconstructions failed, requiring additional surgery to the ACL. 
Females reported a higher rate of reinjury to an ACL graft than males (27% vs. 13%). 
ETIOLOGY: 
 Knee ligaments are often injured in athletic activities, especially when contact is 
a feature, as in American football. Skiing, ice hockey, gymnastics, and other sports may 
also produce enough suddn stress to disrupt knee ligaments. In India wrestling and 
gymnastics activities are the main cause of injury to ligaments.  
 Motor vehicular accidents, especially involving motorcycles, are common causes 
knee ligament disruptions. 
MECHANISM: 
 Palmer describes four mechanisms capable of producing disruptions of the 
ligamentous structures about the knee. 
1. Abduction, flexion, and internal rotation of the femur on the tibia. 
2. Adduction, flexion, and external rotation of the femur on the tibia. 
3. Hyperextension 
4. Anteroposterior displacement. 
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 By far the most common mechanism is abduction, flexion and internal rotation of 
the femur on the tibia when the weight-bearing leg of an athlete is struck from the lateral 
aspect by an opponent. The mechanism results in an abduction and flexion force on the 
knee, and the femur is rotated internally by the shift of the body weight on the fixed tibia. 
This mechanism produces injury on the medial side of the knee, the severity of which 
depends on the magnitude and dissipation of the applied force. The mechanism of 
adduction, flexion, and external rotation of the femur on the tibia is much less common 
and produces the primary disruption laterally. Again the severity of the disruption 
depends on the mangnitude and dissipation of the force applied. Force directed to the 
anterior to the aspect of the extended knee, a hyperextension mechanism, usually injuries 
the anterior cruciate ligament (ACL), and if the force continues or is severe, stretching 
and disruption of the posterior capsule and posterior cruciate ligament (PCL) may result. 
Anteroposterior forces applied to either the femur or the tibia, such as the tibia striking 
the dashboard, may produce injuries to either the anterior or the posterior cruciate 
ligament depending on the tibial displacement. 
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 The severity of the lesion depends on the direction, magnitude, and dissipation of 
the force. When abduction, flexion, and internal rotation of the femur on the tibia occur, 
the medial supporting structures, the tibial collateral ligament, and medial capsular 
ligament are the initial structures injured. If the force is sufficient magnitude, and ACL 
also is often torn. The medial meniscus may be trapped between the condyles of the 
femur and the tibia, and it may be torn at its periphery as the media structures tear, thus, 
producing “the unhappy triad” of O‟Donoghue. Conversely with adduction, flexion and 
external rotation of the femur on the tibia, the fibular collateral ligament usually is 
initially disrupted and depending on the magnitude of the trauma and the displacement, 
is followed by the capsular ligaments, the arcuate ligament complex, popliteus, the 
iliotibial band, the biceps femoris, and not infrequently the common peroneal nerve and 
one or both cruciate ligament.   
CLASSIFICATION: 
    
 A sprain is defined as on injury limited to ligaments (connective tissue attaching 
bone to bone) and a strain as a stretching injury of muscle or its tendionous attachment to 
bone.  
 Sprains are claasified into three degrees of severity. A first-degree sprain of a 
igaments is defined as a tear of a minimum number of fibres of the ligament with 
localizd tenderness but no instability. 
 A second-degree sprain as a disruption of more ligamentous fibres with more loss 
of function and more joint reaction with mild to moderate instability. 
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 A third-degree sprain as a complete disruption of the ligament with resultant 
marked instability. 
 These are often classified as mild, moderate and severe for first, second, and 
third-degree sprains, respectively. 
 The third-degree sprains, i.e. those demonstrating marked instability, may be 
further graded depending on the degree of instability demonstrated during stress testing. 
 A 1-plus instability indicates that the joint surface separate 5mm or less, with     
2-plus instability, they separate between 5 and 10mm and with 3-plus instability, they 
separate 10mm or more. A standardized classification is important for accurate 
communication, and although it obviously is not always precise, it does provide a 
workable scale for clinical purposes. 
DIAGNOSIS: 
Physical examination: 
 Physical examination should be complete, precise, systematic, and carried out as 
soon after the injury as possible so as to minimize problems of severe swelling, tense 
effusion, and the related involuntary muscle spasm that make examination and precise 
diagnosis more difficult. 
 Areas of eccymosis and large effusions are readily noted, although smaller 
effusions may require careful palpation. Haemarthrosis suggest rupture of a cruciate 
ligament, an osteochondral fracture, a peripheral tear in the vascular portion of a 
meniscus, or a tear in the deep portion of the joint capsule. A nonbloody effusion 
suggests an irritative synovitis that may be caused by a degenerative meniscus or a 
chronic process. 
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Abduction, or valgus, stress test: 
   
  
The abduction, or valgus, stress test is performed with the patient supine on the 
examination table. Abduct the extremity off the side of the table and flex the knee 
approximately  30 degree. Place one hand about the lateral aspect of the knee and the 
other supporting the ankle. Gently apply the abduction or valgus stress to the knee, while 
the hand at the ankle externally rotates the leg slightly.  
Adduction, or varus, stress test: 
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 The adduction, or varus, stress test is carried out in a manner similar to the valgus 
stress test, and the test is also performed after xamination of the normal knee. Adduction 
or varus stress is applied by changing the hand to the medial side of the knee and 
applying an adduction or varus force. Examnation should be done both in full extension 
and in 30 degrees of flexion. 
Anterior drawer test: 
   
  
 With patient supine on the examining table, flex the hip to 45 degrees and the 
knee to 90 degrees, placing the foot on the tabletop. Sit on the dorsum of the patient‟s 
foot to stabilize it, and place both hands behind the knee to feel for relaxation of the 
hamstring muscles. Then gently and repeatedly pull and push the proximal part of the leg 
anteriorly and posteriorly, noting the movement of the tibia on the femur. Perform the 
test in three positions of rotation. Initially perform the test with the tibia in neutral 
rotation followed by testing in 30 degrees of external rotation. 
 Internal rotation to 30 degrees may tighten the posterior cruciate enough to 
obliterate an otherwise positive anterior drawer test. Record the degree of displacement 
in each position of rotation and compare with the normal knee. Repeat each maneuver at 
30 and 60 degrees. 
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Posterior drawer test: 
     
 The posterior drawer test with the patient supine, the knee flexed to 90 degrees, 
and the foot secured to the table by sitting on it. Apply a posterior force on the proximal 
tibia opposite to but similar to that applied in the performance of the anterior drawer test. 
Posterior movement of the tibia on the femur demonstrates posterior instability when 
compared with the normal, indicating PCL tear. 
SYMPTOMS: 
 Popping sensation in the knee 
 Severe pain and discomfort 
 Swelling 
 Loss of range of motion 
 Knee stability or buckling 
 Loss of bearing any weight 
 Bleeding within the joints 
 Difficulty in returning to activity 
COMPLICATION: 
 Risk of developing knee osteoarthritis 
 Deterioration of joint cartilage 
 Less range of motion 
 Limping  
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INVESTIGATION: 
a.) Magnetic Resonance Imaging (MRI) 
 To evaluate the ligamentous and cartilaginous structures of knee. 
b.) Arthroscopy: 
 Direct visualization and palpation of partial ACL tears. 
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SPECIAL TREATMENTS: 
VARMAM 
 Varmam is a science dealing with the impact to innumerable nerve junctions of 
thehuman body. The changes occurring in the body on being hit at some specific points 
on thebody directly or indirectly with a particular force is known as varmam.In human 
body from the head to leg there is numerous numbers of points present called in the 
name of varmam. 
 This varmam points may be the nerve junctions, muscular junction or the points 
that the Pranan lived. 
 In our lifestyle varmam is the major cause for muscular sprain, joint pain and low 
back pain.It is present in our inner aspect of our body. 
 In our Siddha literature Varmam is basically divided into two parts  
They are  
1. MEDICINAL ASPECT 
2. DEFENCE & OFFENCE ASPECT 
SYNONYMS AND OTHER NAMES OF VARMAM: 
 Kalam, Adakkam, Marmam, Sutchamam, Vanmam, Yemam, Idu , Karuvi, Kalai, 
Sarvaathma vazhum veedu, Seevan swasam. 
VARMAM – ART AS WELL AS SCIENCE: 
 Varmam is an art as well as a science. As an art it can be employed to attack a 
person to make a permanent or temporary   disability (which is normally not done). It is 
also a science; it helps treat persons from the impact arising from traumatic injuries. 
VARMAM AND OTHER MARTIAL ARTS: 
 Varmam has also accompanied to other martial arts such as silambam, sword 
fighting, kalari etc.  In these arts, the life energy centers of men are made known to 
practitioners to enable them to achieve their ends. 
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SIGNS OF LIFE ENERGY CENTERS IF AFFECTED: 
 Hundreds of life energy centers of human body lie dormant as bones, nerves, 
veins,muscles, joints and inner organs are found either deep or at the surface of the body. 
 Vital lifecenters are dominant on bones and joints. 
 Medium life centre on nerves.  
 Inner life centers on muscles. 
 If the life energy centers are traumatized by hit or cut either directly or indirectly, 
and then whole body is left out of control. In other words the whole body is paralyzed. It 
is manifested by symptoms like fainting, sprain, swelling, bleeding, shivering, fractures, 
dislocations or even death. 
VARMAMS ARE TOTALLY 108 IN NUMBER. 
CLASSIFICATION   OF VARMAM 
There are 2 major classifications present in Varmam. 
They are classified as below 
1. Padu varmam – 12 
 3 is fatal 
 9 is normal 
2. Thodu varmam  
 16 is fatal 
 80 is normal 
BRANCHES OF VARMAM 
1. Vaatha Varmam – 9 
2. Pitha Varmam  – 45 
3. Kaba Varmam  – 25 
4. Hand    – 14 
5. Leg   – 15 
TOTALLY 108 IN NUMBER 
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MAATHIRAI: 
 It is the basic unit of varmam technique. It is the force that attacks a person to 
make symptoms of a particular varmam.  
Depending upon the force it divides into 
1. 1/4 Maathirai  – otherwise called as EEDU 
2. 1/2 Maathirai  – otherwise called as AEMAM 
3. 3/4 Maathirai  – otherwise called as KAALAM 
4. 1 Maathirai  – otherwise called as VARMAM 
 
Varmam points to be manipulated in Muzhangal mootu savvu kayangal patients 
are: 
1. Kaal Mootu Varmam (Varma Viralalavu Nool) 
2. Mozhi Poruthu Varmam  (Varma Noolalavu Nool) 
3. Sirattai Varmam (Varma odivu murivu sara soothiram-1200) 
4. Mootu pathaipu Varmam(Varma Noolalavu Nool) 
1. KAAL MOOTTU VARMAM: 
 ¸Ç¢Â¡É ãðÎÅ÷Áõ Ì½§Á¦¾ýÈ¡ø 
  ¸¡Ã½Á¡ö º¢Ãð¨¼ÂÐ ¿¸ñÎ §À¡Ìõ 
 ¦ÅÇ¢Â¡¸ ÅÕò¾ÁÐ º¸¢ì¦¸¡ð¼¡Ð 
  §Å¸Á¡ö ÁÂì¸¦Á¡Î ¾Ç÷î¨ºÂ¡Ìõ 
 ´Ç¢Â¡É º¢Ãð¨¼Â¨¾ ±ÎòÐ ¨ÅòÐ 
  ¯ÈôÀ¡É À¨ºÂ¢ðÎ ÍüÈ¢ì¦¸ðÊ 
 ÅÇ¢Â¡É ¸ðÎÓ¨È ¦ºöÐ Óý§É 
  ÅÕõ ±ñ¦½ö Å¢ðÎ ¨¸À¡¸õ À¡§Ã 
SYNONYMS: 
 ÓðÎ Å÷Áõ (Å÷Á Ýò¾¢Ãõ-101) 
 ãðÎ Å÷Áõ (¸ñ½¡Ê-500) 
 ¸¡ø ãðÎ Å÷Áõ (Å÷Á Å¢ÃÄÇ× áø) 
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LOCATION: 
“¾¡É¾¢§Ä ÓðÊ¨ºÅ¢ø ãðÌ Å÷Áõ” (Å÷Á ¸ñ½¡Ê-500) 
Located in anterior aspect of knee joint 
2. MOZHI PORUTHU VARMAM: 
 “¸¡Ä¢ý º¢Ãð¨¼ìÌ ´ýÀÐ Å¢ÃÄ¢Ûõ ÅÄò§¾ 
 ¸Ç¢ ¿ÃõÒ Å÷Áõ ¯ûÇÐ" 
      (Å÷Á Å¢Çì¸õ) 
 “¬ÃôÀ¡ ÓðÊÉ¸õ «Ê¿ÃõÀ¢ø ÍÙìÌ Å÷Áõ 
 «¾ý Àì¸õ ºýÉ¢Å÷Áõ º¢Ãð¨¼ Å÷Áõ” 
      (Å÷Á ¿¢¾¡Éõ) 
 “¾¢Ã¢ ¿ÃõÒ §¸¡îÍ Å÷Áõ : ÓðÊý «ÊÂ¢ø 
 ¿ÃõÒ ãýÚ þó¿ÃõÒ¸û «üÚ§À¡É¡ø” 
      (Å÷Á ¬½¢) 
SYNONYMS: 
 ¦Á¡Æ¢¦À¡ÕòÐ Å÷Áõ (Å÷Áõ áÄÇ× 
 ÍÇ¢¿ÃõÒ Å÷Áõ(Å÷Á Å¢Çì¸õ) 
 ÍÙìÌ Å÷Áõ(Å÷Á ¿¢¾¡Éõ) 
 ¾¢Ã¢ ¿ÃõÒ §¸¡îÍ Å÷Áõ(Å÷Á ¬½¢) 
 
LOCATION: 
 Located in popliteal fossae 
3. SIRATTAI VARMAM: 
 “Å¢ð¼¦¾¡Õ ¿¡ö¾¨Ä Å÷Á Á¾¢Ä¢ÕóÐ Â¢ÃñÌ 
  Å¢ÃÄ¢ý §Áø º¢Ãð¨¼ Å÷Áõ Å¢Ã¢òÐî ¦º¡ý§Éý” 
       (Å.´.Ó.ºÃÝò¾¢Ãõ-1200) 
 “«¨È¸¢§Èý º¢øÄ¢Â¾¢ø º¢øÄ¢Å÷Áõ” 
       (Å÷Áº¡Ã¢-205) 
 “ÅÇÁ¡É Óð¼¾¢§Ä º¢Ãð¨¼ Å÷Áõ” 
       (Å÷Á ¿¢¾¡Éõ-300) 
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 “¬ÃôÀ¡ ÓðÊÉ¸õ «Ê¿ÃõÀ¢ý ÍÙìÌ Å÷Áõ 
  «¾ý Àì¸õ ºýÉ¢Å÷Áõ º¢Ãð¨¼ Å÷Áõ” 
       (Å÷Á ¿¢¾¡Éõ-300) 
 “ÓðÊý §Áø Àì¸õ º¢Ãð¨¼ Å÷Áõ” 
       (Å÷Á ¬½¢-108) 
SYNONYMS: 
 º¢Ãð¨¼ Å÷Áõ(Å.´.Ó.ºÃÝò¾¢Ãõ-1200) 
 º¢øÄ¢ Å÷Áõ(Å÷Áº¡Ã¢-205) 
 ÓðÎî º¢Ãð¨¼(Å÷Á áÄÇ× áø) 
LOCATION: 
 Located in patella bone. 
 
4. MOOTU PATHAI VARMAM: 
 “¬ÃôÀ¡ ÓðÊÉ¸õ «Ê ¿ÃõÀ¢ø ÍÙìÌ Å÷Áõ 
  «¾ý Àì¸õ ºýÉ¢Å÷Áõ º¢Ãð¨¼ Å÷Áõ” 
       (Å÷Á ¿¢¾¡Éõ-300) 
 
 “¾¡¦ÉýÈ ÓðÊý ­ÕÀì¸ò¾¢ø ºýÉ¢Å÷Áõ 
  ¾ðÊÊ¸û ¦¸¡ñ¼¡ø ¸¡ø ¾Ç÷ó¾¢Ìõ” 
       (Å÷Á ¿¢¾¡Éõ-300) 
SYNONYMS: 
 À¨¾ôÒ Å÷Áõ(Å÷Á áÄÇ×áø) 
 ºýÉ¢ Å÷Áõ(Å÷Á ¿¢¾¡Éõ-300) 
LOCATION: 
 Situated 6 fingers adjacent to mootu sirattai varmam , in both sides of the legs. 
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MATERIALS AND METHODS 
Comparative clinical trial of siddha drug “Vithu rasa mezhugu”(Internal) and 
“Murivuennai”(External) in the treatment of “Muzhangal mootu savvu kayangal”(Knee 
joint-Ligamant injury) with and without varmam therapy. 
INTERNAL MEDICINE:  
Drug   :    VITHU RASA MEZHUGU 
Reference book :   Anubogavaithiyanavaneetham 
Page No  :   146 
Dosage       :   65 mg(1/2 kundri)  
Adjuvant   :   Palm jaggery 
Duration    :   9 days 
Edition  :  Second edition-May 2001 
Author  :  Hakeem P.M.Abdhullasaayabu 
Publication  :  Thamarai Noolagam 
EXTERNAL MEDICINE: 
Drug   :  MURIVU ENNAI 
Dosage     : Q.S  
Reference  : Varma kannadi-500 
Page no  :  216 
Author  : DR.A. Maria joseph B.Sc.,M.D.,(S) 
Publication  :  G.P.R.Offset printers 
STANDARD OPERATIVE PROCEDURE 
Source of Trial Medicine: 
           The required raw drugs for the preparation of Vithu Rasa Mezhugu (Internal) and 
MurivuEnnai (External) was purchased from a well reputed country shop and the raw 
drugs were authenticated by the competent authority (Medicinal Botany and 
GunapadamDepartment). After that the raw drugs were purified separately and the 
Medicine was prepared in Gunapadam laboratory - National Institute of Siddha. 
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PREPARATION OF TRIAL DRUGS: 
A. Internal Medicine:      
B. Ingredients:  
 Rasam(Hydrargyrum)                                      -17.5gms 
 Serangkottai(Semicarpusanacordium)            -35gms 
Purification of Raw Drugs: 
Serangkottai (Semecarpus anacardium) 
 After removing the knob of serangkottai, it should be soaked in rice washed 
water and buffalo milk for 3 hours each respectively, and they weregently washed with 
water and dried in sunlight. 
Action: 
 Aninflamatory 
Rasam (Hydrargyrum) 
Mercury is grinded with brick powder and turmeric powder 1 hour each 
respectively. The contents were washed with purified water and then  Acalyphaindica 
extract is added . Then the content was boiled till the extract dries. 
Action: 
 Deobstruent 
Method of preparation: 
 Grind these are drugs grainded in a kalvam for 6 hours , till it changes into wax 
consistency.  And then it was carefully stored  ina porcelain container. 
B. External Medicine: 
Ingredients: 
     Coconut oil 
     Neem oil      Equal quantity 
     Komparaku powder 
Purification of drug:  
Coconut oil (Cocos nucifera): 
           Coconut oil and coconut milk are mixed in an equal amount and they were boiled. 
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Action : 
            Anti -inflammatory 
Neem oil (Azadirachta indica): 
            Equalamount of neem oil and neem bark decoction was added, boiled and then 
filtered. 
Action: 
              Anti -inflammatory 
Komparakku (Carteria lacca): 
              After cutting, the stick present inside were removed. 
Action: 
             Anti –arthritic  
             Anti –inflammatory 
Method of preparation: 
 Equal quantity of all the ingredients are mixed and heated. When the mixture 
attainedsoil consistency, the oil was allowed to cool and bottled up. 
 
Drug storage:     
The trial drug Vithu Rasa Mezhuugu was stored in clean and dry container and 
MurivuEnnaiwas stored in clean and dry bottles. 
Dispensing: 
 TheMezhuguwas given in packets and Ennaiis given in dry container. 
VARMAM POINTS APPLIED TO THE PATIENTS: 
 Mootupathaipuvarmam 
 Sirattaivarmam 
 Kaalmootuvarmam 
 Mozhiporuthuvarmam 
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MOOTU PATHAIPU VARMAM: 
Location: 
 This varmam present 6 fingers adjacent to mootu sirattai varmam, in both sides of 
the legs. 
SIRATTAI VARMAM: 
Location: 
 This varmam present in the pattela bone and also , areas around the patella bone. 
This varmam present two fingers above the naaithalai varmam. 
KAAL MOOTU VARMAM: 
Location: 
 This varmam present above the mid point of sirattaivarmam in the anterior aspect 
of knee joint. Three fingers adjacent to this varmam, asaguthiri kannu varmam is located. 
Sometimes the area between asaguthirikannuvarmam can also be taken as 
mootuvarmam. 
MOZHIPORUTHU VARMAM: 
Location: 
 This varmam is present at the back of knee joint. It is present nine fingers 
adjacent to the backsides of mootusirattaivarmam. 
SUBJECT SELECTION: 
             Patients reported with the symptoms ofMuzhangal mootu savvu kayangal-knee 
joint ligament injury were subjected to screening using their screening Profoma. Then 
they were allowed for the study, subjected to the fulfillment of the following criteria. 
INCLUSION CRITERIA: 
 Age : 20 - 60Yrs 
 Sex : Both male and female 
 Pain and tenderness , often sudden and severe in the knee joints 
 Pain gets worse while walking. 
 Swelling present in the knee joint. 
 A feeling of looseness in the knee joint. 
 Patients willing to undergo radiological investigation and Laboratory 
investigations. 
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 Patients willing to sign the informed consent stating that he/she will 
conscientiously  stick to the treatment during 48days but can opt out of the 
trial of his/her own conscious discretion. 
EXCLUSION CRITERIA: 
 Complete ligament tear of the knee joint 
 Posterior cruciate ligament tear 
 Evidence of bony fractures in X-rays 
 H/o Cardiac diseases 
 S  H/o Diabetes mellitus 
 H/o Rheumatoid arthritis 
 H/o Chronic kidney disease   
 Pregnancy and lactation      
 Septic arthritis        
 Gonococcal arthritis  
 Psoriatic arthritis 
 Patient with any other serious systemic illness.  
 
WITHDRAWAL CRITERIA: 
 Intolerance to the drug and development of adverse reactions during drug trial. 
 Poor patient compliance and defaulters. 
 Patient turning unwilling to continue in the course of clinical trial. 
 Occurrence of any serious illness 
TESTS AND ASSESSMENTS: 
A. Clinical assessment  
B. Laboratory investigations 
C. Radiological investigations 
D.  Siddha system assessment 
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A.CLINICAL ASSESSMENT: 
 Pain  
 Swelling  
 Stiffness  
 Tenderness 
 Restricted movements 
 Positive  knee joint ligament test 
KNEE JOINT LIGAMENT EXAMINATION: 
1. Anterior drawer sign: 
The anterior drawer test examine for any tearing or laxity of the anterior cruciate 
ligament. 
2. Posterior drawer test: 
The posterior drawer test is used to examine the posterior cruciate ligament. 
3. Valgus test: 
The valgus stress test checks for medial joint laxity , which usually represents an 
injury to the medial collateral ligament. 
4. Varus test: 
The varus stress test checks for joint laxity on the outside of the knee , which 
usually represents an injury to the lateral collateral ligment. 
5. McMurray‟s test: 
This test checks for meniscal tears and other internal derangement in the knee. 
B. Routine investigation: 
Blood: 
 Hb 
 Total WBC Count 
 DC-  Polymorphs 
1. Lymphocytes  
2. Eosinophil  
3. Monocytes  
4. Basophils  
 Total RBC count 
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 ESR 
½ Hr:                 1 Hr: 
 Blood sugar 
Fasting:               PP: 
Urine: 
 Albumin 
 Sugar 
 Deposits 
 
Renal function tests: 
 Urea 
 Creatinine 
 Liver function tests: 
 Serum total bilirubin 
 Direct bilirubin 
 Indirect bilirubin 
 Serum Alkaline phosphatases 
 SGOT 
 SGPT 
 SPECIFIC INVESTIGATIONS: 
CRP 
ASO TITRE 
RA FACTOR 
C.RADIOLOGICAL INVESTIGATIONS: 
  MRI (Magnetic Resonance Imaging) 
 
D. SIDDHA PARAMETERS: 
Envagaithervugal: 
  Naadi 
Sparisam 
Naa 
Niram 
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Mozhi 
Vizhi 
Malam 
Moothiram 
- NeerkKuri 
- Neikkuri 
DATA COLLECTION FORMS: 
 Required information was collected from each patient by using the following 
forms: 
FORMS: 
 Form I   Screening and selection Proforma 
 Form II   History taking & Clinical assessment Proforma 
 Form III   Laboratory investigation Proforma 
 Form IV  Drug compliance form 
 Form V  Patient information sheet 
 Form VI  Consent form 
 Form VII  Withdrawal form  
 Form VIII  Dietary Advice form 
 
STUDY ENROLLMENT:  
Patients who were reported at the OPD with the clinical symptoms of 
Muzhangalmootusavvukayangal (Ligament injury-knee joint) was examined clinically 
and then enrolled in the study based on the inclusion and exclusion criteria.  
The patients who were enrolled was informed (Form VI) about the study, trial drug, 
possible outcomes and the objectives of the study in the language and terms 
understandable to them andinformed consent was obtained  from them in writing format, 
in the consent form (Form VI). All those patients were given unique registration card in 
which patients‟ Registration number of the study, Address, Phone number and Doctor‟s 
contact details etc. were given, so as to report easily when any complications arises. 
Complete clinical history, complaints and duration, examination findings and 
laboratory investigations are recorded in the prescribed Profoma. Patients were   advised  
to take the trial drug and to follow the appropriate dietary advice. 
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CONDUCT OF THE STUDY: 
The trial drugs Vithu Rasa Mezhugu (Internal) was given for 9days and 
MurivuEnnai(External)was given continuously for 48 days for all the 30 patients.  Out of 
those 30 patients, 15 patients areprovided with varmam therapy. Patients were requested 
to visit the hospital OPD once in seven days for this study. Willing  cases were admitted 
in the IPD and progress was assessed daily. In every visit,  the clinical assessment was 
done and prognosis was noted in the prescribed profomas in the presence of Faculty 
members of Dept. of SirappuMaruthuvam. Laboratory investigations and radiological 
investigation are done before the administration of the drug and the last day of the trial, 
laboratory investigation done again for screening.DATA ANALYSIS: 
After enrolling the patient for the study, a separate file for each patient was 
opened and all forms were kept in the file.  Study No. and Patient No. was written on the 
top of file for easy identification.  Whenever the patient visited OPD during the study 
period, their file was taken and necessary entries was made at the assessment form or 
other suitable form.  The screening forms were filed separately.  The data recordings was 
monitored for completion and adverse event by pharmacovigilance committee. And then,  
All forms were  scrutinized in presence of Investigators by Sr. Research Officer 
(Statistics) for logical errors and incompleteness of data to avoid any bias.  No 
modification in the results was permitted for unbiased report. 
PHARMOCOVIGILANCE 
ADVERSE EFFECT/SERIOUS EFFECT MANAGEMENT 
If the trial patient developed any adverse reaction, he/she was immediately 
withdrawn from the trial and proper management was given in OPD of National Institute 
of Siddha and the same was informed to the Pharmaco-vigilance committee of NIS. 
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OUTCOME: 
Primary outcome: 
 Primary outcome of the study is pain relieving and it will be assessed by the 
following methods: 
KOOS Scoring instructions 
Assign the following scores to the boxes: 
None Mild Moderate Severe Extreme 
          
0 1 2 3 4 
Each subscale score is calculated independently. Calculate the mean score of the 
individual items of each subscale and divide by 4 (the highest possible score for a single 
answer option). Traditionally in orthopedics, 100 indicates no problems and 0 indicates 
extreme problems. The normalized score is transformed to meet this standard. 
WOMAC - How to score from the KOOS 
Assign scores from 0 to 4 to the boxes as shown above. To get original WOMAC 
Scores, sum the item scores for each subscale. If you prefer percentage scores in 
accordance with the KOOS, use the formula provided below to convert the original 
WOMAC scores. 
Transformed scale = 100 - actual raw score x 100   
  maximum score   
      
WOMAC subscores Original score = sum of Maximum score 
  the following items   
Pain P5-P9 20 
Stiffness S6-S7 8 
Function A1-A17 68 
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ETHICAL ISSUES : 
1. To prevent any infection, while collecting blood sample from the patient, only 
disposable syringes, disposable gloves, with proper sterilization of laboratory 
equipments was used.     
2. No other external or internal medicines were used, other than the trial drug for 
Muzhangal mootu savvu kayangal. There was no infringement on the rights of the 
patient. 
3. The data collected from the patient was kept confidential.  
4. Only After getting the consent of the patient (through consent form in their own 
vernacular language), they were enrolled in the study. 
5. Treatment was provided free of cost. 
6. In any adverse reaction observed during the trial, the patients were withdrawn 
andgiven alternative treatment at National Institute of Siddha for further 
management.  
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DRUG REVIEW 
INTERNAL MEDICINE:VITHURASA MEZHUGU 
PROPERTIES OF DRUGS: 
     RASAM 
English name : Hydrargyram(Mercury quick silver) 
Organoleptic character :         
Taste :  Inippu(sweet), Pulippu(sour), Uppu(salty),  
  kaippu(bitter),                               
  Kaarpu(pungent), Thuvarpu(astringent). 
Potency :  Veppam and Thatpam 
¦À¡ÐÌ½õ 
“Å¢Æ¢§¿¡ö ¸¢Ãó¾¢ÌýÁõ ¦ÁöîÝ¨ÄÒñÌð 
 ¼Æ¢¸¡Ä¢ø Å¢ó¾Å¢É¡ø «ò¨¾-ÅÆ¢Â¡ö 
 ÒÃ¢Ô Å¢¾¢ Â¡Ð ÒÃ¢Â¢§É¡ ¦ÂøÄ¡õ 
 ­Ã¢ÔÅ¢¾¢ Â¡Ð Á¢ø¨Ä” 
Action: 
 Deobstruvent 
 Anti syphilitic 
 Antibilious 
 Nutrient 
 Alterative 
 Sialogogue 
 Laxative 
 Diuretic 
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SERANKOTTAI 
Botanical name :  Semecarpusanacordium 
English name :  Marking nut tree, Original cashew 
Family : Anacardiaceae 
Organoleptic character : 
Taste :  Kaippu(Bitter), Viruviruppu 
Potency :  Veppam 
Division :  Kaarpu(Pungent) 
¦À¡ÐÌ½õ 
“Ìð¼õ ¸Â§Ã¡¸í ¦¸¡øÖõ Å¢¼À¡¸ó 
 Ðð¼ó ¾Õ¸¢ÕÁ¢ Ý¨ÄÔõ §À¡õ-Áð¼ÄÕí 
 Üó¾ýÁÂ¢ §Ä¸¢Ãó¾¢ý Üð¼õ§À¡ ¦ºí¨¸Â¢ø 
 ²óÐ §ºí ¦¸¡ð¨¼¾¨É §Â 
 
 §ºí¦¸¡ð¨¼ ¦Áöò¾¢Á¢¨Ãò ¾£Ã¡ì ¸ÊÅ¢¼ò¨¾ô 
 À¡í¦¸¡ðÎ ãÄò¨¾ô ÀüÈÚìÌõ-¬í¦¸ðÊì 
 ¦¸¡øÖõÅ¡ ¾ó¾¢§É¡Î ÌýÁò¨¾ ÔõÁ¾¨É 
 ¦ÅøÖõ «Â¢ü¸ñ§½¡ö Å¢û”. 
Chemical constituents: 
 Anacordic acid, Cardol, Catechol, Anacardol, Fixed oil, Semecarpol, Bhilawanol 
Actions : 
 Alterative 
 Caustic  
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EXTERNAL MEDICINE : MURIVUENNAI 
     KOMPARAKKU 
English name :  Caterialacca (or) Coccuslacca (or)  
  Tachardialacca 
Organoleptic charecters : 
Taste :  Thuvarpu(Astringent), Kaippu(Bitter) 
Potency :  Veppam 
Division :  Kaippu(Bitter) 
¦À¡ÐÌ½õ 
“Ìð¼ Áº¢÷ìÌ À¢ò¾í ÌýÁÁ¢¨Ã ¦ÀýÒÕì¸¢ 
 ÀðÊÎ Òñ½¡¸îÝ÷ Àí¸§¿¡ö ¦¾¡ð§À¡ 
 ¿Ã¸ÃìÌ ºó¾¢ÍÃ ¨ÁÂÁ¢¨Åì ¦¸¡ø§Ä¡ 
 ÁÃ¸ÃìÌá¨Ä ÂÈ¢” 
Actions : 
 Astringents  
 Alterative  
     THENGAIENNAI 
Botanical name :  Cocosnucifera 
English name :  Coconut tree, coconut palm 
Family  : Aracaceae 
Organoleptic character : 
Taste  :  Inippu(Sweet) 
Potency :  Thatpam 
Division :  Inippu(Sweet) 
¦À¡ÐÌ½õ 
“§¾í¸¡Â¢ ¦ÉöÂ¾É¡ü È¢Â¡øÅÕÒñ§À¡õ 
 À¡í¸¡¸ì Üó¾ü À¼÷ó§¾Ú- ¿£í¸¡¾ 
 ÀøÄÊÂ¢ý §É¡Ôõ À¼÷¾¡ Á¨Ãº¢ÃíÌõ 
 «øÄÈô §À¡¦Áý ÈÈ¢”. 
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Chemical composition: 
Lauric acid, Myristic acid, Caprylic acid, Capric acid, Caproic acid, Palmitic 
acid, Oleic acid, Palmitoleic acid, Linoleic acid, Linolenic acid, Stearic acid 
Actions : 
 Refrigerant 
 Aperient 
 Nutrient 
 Diuretic 
VEPPENNAI 
Botanical name    : Azadirachtaindica 
English name     : Margosa tree,  Neem tree, Indian lilac 
Family     : Meliaceae 
Organoleptic character: 
Taste       : Kaippu(Bitter) 
Potency     : Veppam 
Division     : Karppu(Pungent) 
¦À¡ÐÌ½õ 
 “Å¡¾õ§À¡õ À¢ò¾Á¢Ìõ Á¡È¡ì¸¢ Ãó¾¢¦Â¡Î 
 §Á¡Ð¸ÃôÀ¡ýº¢ÃíÌÓýÉ¢º¢×õ-µÐ¼Ä¢ý 
 ¿¡ôÀ ÏÚÍÃÓ ¿¡ÎºýÉ¢ Ôó¦¾¡¨ÄÔõ 
 §ÅôÀ¦¿ö ¦Âý¦È¡Õì¸¡ø Å¢ûÙ" 
Chemical composition: 
 Azadirachtin, Nimbin, Stigmasterol, Campesterol, beta-sitosterol. 
Actions : 
 Stimulant 
 Antiseptic 
 Insecticide 
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MURIVU ENNAI 
 
 
 
 
 
 
VITHU RASA MEZHUGU 
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OBSERVATION AND RESULTS 
1. Age Distribution 
2. Gender Distribution 
3. Gunam 
4. Yakkai illakanam 
5. Seasonal Distribution 
6. Land And Disease 
7. Socio-Economic Status 
8. Dietary Habits 
9. Occupational Status 
10. Duration Of Illness 
11. Distribution Of Mukkutram 
12. Ennvagai Thervugal 
13. Neikuri  
14. Naadi 
15. Distribution of Udal Thathukal 
16. Clinical Features 
17. Involvement Of Knee Joints 
18. Precipitating Factors 
19. Outcome Measurement 
20. Results After Treatment 
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1. AGE DISTRIBUTION: 
        S.NO Age(year) Number of cases Percentage% 
        1. 20-30 7 23.3% 
        2. 31-40 13 43.3% 
        3. 41-50 10 33.3% 
        4. Total 30 100% 
 
 
Observation: 
 The patients were selected from all age groups as given above and the maximum 
numbers of patients(13) ie. 43.30%, were in the age between 31and 40. 
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2. GENDER DISTRIBUTION: 
    S.NO Gender Number of cases Percentage% 
     1. Males 20 66.7% 
     2. Females 10 33.3% 
     3. Total 30 100% 
 
 
Observation: 
 Among the 30 patients selected for this study, male were 33.3% and female 
were 66.7%.  
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3.GUNAM (QUALITY AND CHARACTER) 
SI. NO Gunam No of cases Percentage 
1  Sathuva gunam - - 
2 Raso gunam 30 100 
3 Thamo gunam - - 
 
 
Observation : 
 All the patients (100%) had Raso gunam. 
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4. YAAKAI  ILAKKANAM (PHYSICAL CONSTITUTION) 
 
SI. NO Yaakai ilakkanm No of cases Percentage 
1 Vatha udal - - 
2 Pitha udal - - 
3 Kaba udal - - 
4 Vaathapitha udal 12 40% 
5 Vaathakaba udal 3 10% 
6 Pithavaatha udal 10 33.33% 
7 Pithakaba udal 5 16.67% 
 
Observation : 
 Out of 30 cases, 12 patients had Vaathapitha udal, 3 patients had Vaathakaba 
udal, 10 patients had Pithavaatha udal and 5 patients had Pithakaba udal 
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5. SEASONAL DISTRIBUTION : 
S.No. Season Number of cases Percentage% 
1 Kaar kaalam 3 10% 
2 Koothir kaalam 2 6.7% 
3 Munpani  kaalam 25 83.3% 
4 Total 30 100% 
 
 
 
Observation: 
 Out of 30 patients, 3 patients reported in Karkaalam, 2 patients in Koothirkaalam 
and 25 patients reported in Munpanikaalam. 
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6. LAND AND DISEASES: 
S.No. Thinai Number of cases Percentage% 
1 Kurinji - - 
2 Mullai 3 10% 
3 Marutham 9 30% 
4 Neithal 18 60% 
5 Paalai - - 
6 Total 30 100% 
 
Observation: 
 Out of 30 patients, 3 patients were from Mullai, 9 patients from Marutham and 
18 patients from Neithal. 
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7. SOCIO- ECONOMIC STATUS: 
 
S.No Socio- economic status Number of 
cases 
Percentage% 
1 Higher economic status 3 10% 
2 Middle economic status 27 90% 
3 Lower economic status - - 
4 Total 30 100% 
 
 
 
Observation: 
 Out of 30 cases 10% cases from upper and 90% cases were from middle 
economic status. 
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8. DIETARY HABITS: 
S.NO Dietary habits Number of cases Percentage% 
1 Vegetarian 5 16.7% 
2 Non- vegetarian 25 83.3% 
3 Total 30 100% 
 
 
 
Observation : 
 Out of 30 cases 83.3% of cases were Non-vegetarians and 16.7% of cases were 
Vegetarians 
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9. OCCUPATIONAL STATUS : 
S.NO Occupation Number of cases Percentage% 
1 Casier  1 3.3% 
2 Sales man 1 3.3% 
3 Teacher 1 3.3% 
4 Electrician 2 6.7% 
5 Home maker 9 30% 
6 Aditior  2 6.7% 
7 Airforce offcer 3 10% 
8 Student 2 6.7% 
9 Supervisor 7 23.3% 
10 Lawyer 1 3.3% 
11 Staffnurse 1 3.3% 
12 Total 30 100% 
 
 
Observation: 
 The majority of patients (30%) in this study were Home maker. 
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10. DURATION OF ILLNESS : 
 
S.NO Duration of illness Number of cases Percentage% 
1 15 days-1month 9 30% 
2 1-3 months 10 33.3% 
3 3-6 months 6 20% 
4 6months-1 year 5 16.7% 
5 Total 30 100% 
 
 
Observation: 
 Among 30 cases, the duration of  illness were 33.3% cases 1 months to 3 months, 
30% cases in 15 days to 1 month, 20% cases in 3 months to 6 months, 16.7% cases in 6 
months to 1 year. 
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11. DISTRIBUTION OF MUKKUTRAM: 
 The derangements of Vatham, Pitham and Kabam in MMSK are as follows 
a) Vatham 
SI. No Classification of Vatham No of cases Percentage 
1  Pranan - - 
2 Abanan - - 
3 Uthanan - - 
4 Samanan 30 100% 
5 Viyanan 30 100% 
6 Naagan - - 
7 Koorman - - 
8 Kirukran - - 
9 Devathaththan - - 
10 Dhananjeyan - - 
 
Observation: 
 Out of 30 cases Viyanan and Samanan were affected in all the 30 patients 
(100%).  
 
b) Pitham 
SI. NO Classification of Pitham No of cases Percentage 
1  Anarpitham - - 
2 Ranajgapitham - - 
3 Sathagapitam 30 100% 
4 Alosagapitham - - 
5 Pirasagapitham - - 
 
Observation: 
 Out of 30 cases saathagam was affected in almost all the 30 cases (100%) 
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c) Kabam 
SI. NO Classification of Pitham No of cases Percentage 
1  Avalambagam - - 
2 Kilethagam - - 
3 Pothagam - - 
4 Tharpagam - - 
5 Santhigam 30 100% 
 
Observation: 
 Out of 30 cases Santhigam was affected in almost all the 30 cases (100%). 
12. ENVAGAI THERVUGAL : 
 In Siddha system of Medicine, the eight types of investigative procedure were 
adopted for clinical approach and diagnosis. The investigations were done properly and 
observations were tabulated. 
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Neikkuri: 
S.NO Neikkuri BEFORE AFTER 
NO.OF 
CASES 
PERCENTAGE NO.OF 
CASES 
PERCENTAGE 
1 Vaatham 3 10% 10 33.33% 
2 Pitham 12 40% 8 26.66% 
3 Kabam 15 50% 12 40% 
4 Total 30 100% 30 100% 
 
  
  
Observation : 
 Out of 30 cases, Before treatment, in 50% of cases Neikkuri was found as 
Vaatham, 40% of cases found as pitham and 10% cases found as kabam. After treatment, 
in 33.33% of cases Neikkuri was found as Vaatham, 26.66% of cases found as pitham 
and 40% cases found as kabam. 
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14. NAADI: 
S.No Naadi BEFORE AFTER 
No. of cases Percentage% No.of cases Percentage% 
1 Vaatha pitham 8 26.7% 20 66.66% 
2 Vaatha kabam - - -  
3 Pitha vaatham 21 70% 6 20% 
4 Pitha kabam 1 3.3% 2 6.66% 
5 Kaba vaatham - - 2 6.66% 
6 Kaba pitham - - - - 
7 Total 30 100% 30 100% 
 
Observation : 
 Among 30 cases, Before treatment, vaathapitham naadi was found in8 patients, 
21 were found in Pithavaatham and 1 had pithakabavatham. After treatement, 
vaathapitham naadi was found in 20 patients, 6 were found in Pithavaatham, 2 had 
pithakabam and 2 had kabavaatham. 
15. DISTRIBUTION OF UDAL KATTUKAL 
SI. No Udal kattukal No of cases Percentage 
1  Saaram 30 100% 
2 Senneer - - 
3 Oon 30 100% 
4 Kozhupu - - 
5 Enbu - - 
6 Moolai - - 
7 Sukkilam/suronitham - - 
 
Observation: 
 The Seven thathukkal which constitute our body structure and help to maintain 
the normal physiological functions. 
 Among the 7 Udal Kattugal, Saaram and Oon  were affected in all the 30 cases 
(100%). 
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17. INVOLVEMENT OF KNEE JOINTS: 
Involvement of knee joints Number of cases Percentage% 
Both knee joints 0 - 
Single knee joint only 30 100% 
Total 3 100% 
 
Observation : 
 Out of 30 cases single knee joints were affected in 30 patients (100%). 
18. PRECIPITATING FACTOR: 
 
Precipitating factor Number of cases Percentage% 
H/o trauma 30 100% 
Obesity - - 
Occupation related - - 
Total 30 100% 
 
 
Observation: 
 Out of 30 cases 100% of cases were underwent Trauma. 
 
 
H/O TRAUMA
OBESITY
OCCUPATION RELATED
0 20 40 60 80 100
100%
0
0
PRECIPITATING FACTOR
PRECIPITATING FACTOR
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RESULTS OF VARMAM MANIPULATION ACCORDING TO KOOS SCORE 
CLINICAL IMPROVEMENT (SYMPTOMS SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K08130 Sakthi valli 26 M 17.86 71.43 
2 I15391 Mohan 37 M 21.43 85.71 
3 K60982 Kavitha 38 F 25 71.43 
4 K96010 Muralikrishnan 40 M 17.86 82.14 
5 H02677 Ravichandran 48 M 28.57 82.14 
6 L02052 Sivakumar 44 M 17.86 82.14 
7 L03153 Sarava kumar 30 M 25 82.14 
8 5525 Maheshkumar 20 M 32.14 75 
9 F002104 Aruldoss 47 M 21.43 71.43 
10 L04732 K.Anand  28 M 21.43 75 
11 J18103 Ramani 38 F 25 71.43 
12 5556 Rajesh 38 M 25 78.57 
13 5565 Gokulnath 22 M 25 78.57 
14 K86778 Akshayashree 37 F 10.71 82.4 
15 L18268 Mathivanan 37 M 17.86 71.43 
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CLINICAL IMPROVEMENT(PAIN SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K08130 Sakthi valli 26 M 16.67 80.56 
2 I15391 Mohan 37 M 13.89 75 
3 K60982 Kavitha 38 F 19.4 72.22 
4 K96010 Muralikrishnan 40 M 16.67 75 
5 H02677 Ravichandran 48 M 19.4 83.33 
6 L02052 Sivakumar 44 M 19.4 86.11 
7 L03153 Sarava kumar 30 M 25 75 
8 5525 Maheshkumar 20 M 25 86.11 
9 F002104 Aruldoss 47 M 16.67 69.44 
10 L04732 K.Anand  28 M 19.44 83.33 
11 J18103 Ramani 38 F 13.89 69.44 
12 5556 Rajesh 38 M 27.78 83.33 
13 5565 Gokulnath 22 M 19.44 80.56 
14 K86778 Akshayashree 37 F 22.22 83.33 
15 L18268 Mathivanan 37 M 16.67 69.44 
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CLINICAL IMPROVEMENT(FUNTION, DAILY LIVING SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K08130 Sakthi valli 26 M 20.59 82.35 
2 I15391 Mohan 37 M 23.53 72.06 
3 K60982 Kavitha 38 F 19.12 73.53 
4 K96010 Muralikrishnan 40 M 17.65 76.47 
5 H02677 Ravichandran 48 M 20.59 82.35 
6 L02052 Sivakumar 44 M 13.24 77.94 
7 L03153 Sarava kumar 30 M 22.06 80.88 
8 5525 Maheshkumar 20 M 23.53 80.88 
9 F002104 Aruldoss 47 M 16.18 70.59 
10 L04732 K.Anand  28 M 27.94 80.88 
11 J18103 Ramani 38 F 14.71 70.59 
12 5556 Rajesh 38 M 23.53 83.82 
13 5565 Gokulnath 22 M 19.12 72.06 
14 K86778 Akshayashree 37 F 13.24 86.76 
15 L18268 Mathivanan 37 M 20.59 73.53 
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CLINICAL IMPROVEMENT(FUNTION, SPORTS AND RECREATONAL 
ACTIVITES SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K08130 Sakthi valli 26 M 10 60 
2 I15391 Mohan 37 M 10 65 
3 K60982 Kavitha 38 F 10 70 
4 K96010 Muralikrishnan 40 M 15 70 
5 H02677 Ravichandran 48 M 15 65 
6 L02052 Sivakumar 44 M 10 80 
7 L03153 Sarava kumar 30 M 15 65 
8 5525 Maheshkumar 20 M 15 80 
9 F002104 Aruldoss 47 M 15 60 
10 L04732 K.Anand  28 M 20 70 
11 J18103 Ramani 38 F 20 70 
12 5556 Rajesh 38 M 10 75 
13 5565 Gokulnath 22 M 20 70 
14 K86778 Akshayashree 37 F 10 75 
15 L18268 Mathivanan 37 M 20 65 
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CLINICAL IMPROVEMENT(QUALITY OF LIFE SCORE) 
  
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K08130 Sakthi valli 26 M 31.25 75 
2 I15391 Mohan 37 M           25 81.25 
3 K60982 Kavitha 38 F 12.5 81.25 
4 K96010 Muralikrishnan 40 M 18.75 75 
5 H02677 Ravichandran 48 M 18.75 75 
6 L02052 Sivakumar 44 M 12.5 81.25 
7 L03153 Sarava kumar 30 M 18.75 81.25 
8 5525 Maheshkumar 20 M 25 81.25 
9 F002104 Aruldoss 47 M 18.75 75 
10 L04732 K.Anand  28 M 25 75 
11 J18103 Ramani 38 F 25 68.75 
12 5556 Rajesh 38 M 18.75 81.25 
13 5565 Gokulnath 22 M 18.75 87.5 
14 K86778 Akshayashree 37 F 25 87.5 
15 L18268 Mathivanan 37 M 18.75 75 
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RESULTS OF WITHOUT VARMAM MANIPULATION ACCORDING TO 
KOOS SCORE 
CLINICAL IMPROVEMENT(SYMPTOMS SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K64880 Meenatchi 46 F 32.14 78.57 
2 L13330 Bhuvaneshwari 35 F 14.29 82.14 
3 K27997 Shakilabanu 40 F 10.71 71.43 
4 J63195 A.K.Singh 48 M 14.29 64.29 
5 L15438 Chandramohan 35 M 32.14 75 
6 K99836 A.Anand 42 M 17.86 85.71 
7 L08775 Pandey 29 M 14.29 85.71 
8 H47521 Nagaraj 48 M 14.29 71.43 
9 L08785 Natarajan 27 M 32.14 78.57 
10 L11402 A.Saravanan 44 M 21.43 82.14 
11 L03321 Rajesh 33 M 28.57 78.57 
12 L13877 Sasikala 46 F 25 78.57 
13 J31798 Gokila 34 F 17.86 75 
14 L22271 Jayanthi 33 F 14.29 78.57 
15 D098267 Kalaiselvi 48 F 14.29 85.7 
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CLINICAL IMPROVEMENT(PAIN SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K64880 Meenatchi 46 F 33.33 80.56 
2 L13330 Bhuvaneshwari 35 F 13.89 86.11 
3 K27997 Shakilabanu 40 F 16.67 72.2 
4 J63195 A.K.Singh 48 M 16.67 63.89 
5 L15438 Chandramohan 35 M 27.78 80.56 
6 K99836 A.Anand 42 M 30.56 75 
7 L08775 Pandey 29 M 30.56 72.22 
8 H47521 Nagaraj 48 M 27.78 77.78 
9 L08785 Natarajan 27 M 33.33 86.11 
10 L11402 A.Saravanan 44 M 22.22 80.56 
11 L03321 Rajesh 33 M 33.33 80.56 
12 L13877 Sasikala 46 F 27.78 80.56 
13 J31798 Gokila 34 F 13.89 77.78 
14 L22271 Jayanthi 33 F 22.22 80.56 
15 D098267 Kalaiselvi 48 F 16.67 83.33 
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CLINICAL IMPROVEMENT(FUNCTION, DAILY LIVING SCORE) 
 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K64880 Meenatchi 46 F 32.35 79.41 
2 L13330 Bhuvaneshwari 35 F 17.65 80.88 
3 K27997 Shakilabanu 40 F 19.12 76.47 
4 J63195 A.K.Singh 48 M 16.18 67.65 
5 L15438 Chandramohan 35 M 25 82.35 
6 K99836 A.Anand 42 M 22.06 83.82 
7 L08775 Pandey 29 M 29.41 75 
8 H47521 Nagaraj 48 M 22.06 79.41 
9 L08785 Natarajan 27 M 32.35 82.35 
10 L11402 A.Saravanan 44 M 25 79.4 
11 L03321 Rajesh 33 M 23.53 83.82 
12 L13877 Sasikala 46 F 27.94 83.82 
13 J31798 Gokila 34 F 22.06 83.82 
14 L22271 Jayanthi 33 F 22.06 77.94 
15 D098267 Kalaiselvi 48 F 22.06 73.53 
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CLINICAL IMPROVEMENT(FUNCTION, SPORTS AND RECREATIONAL 
ACTIVITIS SCORE) 
 
 
 
 
S.NO OPD/IPD 
NO NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K64880 Meenatchi 46 F 30 70 
2 L13330 Bhuvaneshwari 35 F 15 70 
3 K27997 Shakilabanu 40 F 10 65 
4 J63195 A.K.Singh 48 M 10 60 
5 L15438 Chandramohan 35 M 20 80 
6 K99836 A.Anand 42 M 15 70 
7 L08775 Pandey 29 M 30 75 
8 H47521 Nagaraj 48 M 20 70 
9 L08785 Natarajan 27 M 30 80 
10 L11402 A.Saravanan 44 M 25 65 
11 L03321 Rajesh 33 M 15 65 
12 L13877 Sasikala 46 F 30 70 
13 J31798 Gokila 34 F 15 70 
14 L22271 Jayanthi 33 F 25 75 
15 D098267 Kalaiselvi 48 F 15 65 
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CLINICAL IMPROVEMENT(QUALITY OF LIFE SCORE) 
 
 
 
 
S.NO OPD/IPD 
NO NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K64880 Meenatchi 46 F 37.50 81.25 
2 L13330 Bhuvaneshwari 35 F 12.5 81.25 
3 K27997 Shakilabanu 40 F 12.5 68.75 
4 J63195 A.K.Singh 48 M 12.5 62.5 
5 L15438 Chandramohan 35 M 25 75 
6 K99836 A.Anand 42 M 12.5 81.25 
7 L08775 Pandey 29 M 31.25 81.25 
8 H47521 Nagaraj 48 M 12.5 75 
9 L08785 Natarajan 27 M 37.5 75 
10 
L11402 A.Saravanan 
44 M 18.75 81.25 
11 
L03321 Rajesh 
33 M 31.25 81.25 
12 
L13877 Sasikala 
46 F 31.25 75 
13 
J31798 Gokila 
34 F 12.5 68.75 
14 
L22271 Jayanthi 
33 F 31.25 75 
15 
D098267 Kalaiselvi 
48 F 12.5 81.25 
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RESULT OF VARMAM MANIPULATION ACCORDING TO KOOS SCORE 
 
 
 
S.NO OPD/IPD 
NO NAME AGE SEX 
KOOS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K08130 Sakthi valli 26 M 19 76.8 
2 I15391 Mohan 37 M 21.7 75 
3 K60982 Kavitha 38 F 12.5 73.2 
4 K96010 Muralikrishnan 40 M 17.3 76.2 
5 H02677 Ravichandran 48 M 20.8 79.8 
6 L02052 Sivakumar 44 M 14.9 81 
7 L03153 Sarava kumar 30 M 22.6 78 
8 5525 Maheshkumar 20 M 25 81 
9 F002104 Aruldoss 47 M 17.7 69.6 
10 
L04732 K.Anand  
28 M 23.8 78.6 
11 
J18103 Ramani 
38 F 17.9 70.2 
12 
5556 Rajesh 
38 M 22.6 81.5 
13 
5565 Gokulnath 
22 M 20.2 76.2 
14 
K86778 Akshayashree 
37 F 15.5 83.9 
15 
L18268 Mathivanan 
37 M 20 73.2 
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RESULT OF WITHOUT VARMAM MANIPULATION ACCORDING TO KOOS 
SCORE 
S.NO 
OPD/IPD 
NO 
NAME AGE SEX 
SYMPTOMS SCORE 
BEFORE 
TREATMENT 
(%) 
AFTER 
TREATMENT 
(%) 
1 K64880 Meenatchi 46 F 32.7 78.6 
2 L13330 Bhuvaneshwari 35 F 15.9 81 
3 K27997 Shakilabanu 40 F 15.5 72.6 
4 J63195 A.K.Singh 48 M 14.9 64.9 
5 L15438 Chandramohan 35 M 26.2 79.8 
6 K99836 A.Anand 42 M 21.4 80.4 
7 L08775 Pandey 29 M 27.4 76.8 
8 H47521 Nagaraj 48 M 20.8 76.2 
9 L08785 Natarajan 27 M 32.7 81.5 
10 L11402 A.Saravanan 44 M 23.2 78.6 
11 L03321 Rajesh 33 M 26.2 79.8 
12 L13877 Sasikala 46 F 28 79.8 
13 J31798 Gokila 34 F 17.9 78 
14 L22271 Jayanthi 33 F 22 78 
15 D098267 Kalaiselvi 48 F 17.9 77.4 
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STATISTICAL ANALYSIS 
All collected data were entered into MS Excel software using different columns 
as variables and rows as patients. SPSS software was used to perform statistical analysis. 
Basic descriptive statistics include frequency distributions and cross tabulations were 
performed. The quantity variables wre expressed as Mean ± Standard Deviation and 
qualitative data as percentage. A probability value of <0.05 was considered to indicate as 
statistical significance. Paired „t‟ test was performed for determining the significance 
between before and after treatment. 
ACCORDING TO KOOS SCORE 
BEFORE AND AFTER TREATMENT 
Symptom score Sample 
size 
Mean±SD 95% 
confidence 
interval 
Significant 
Before treatment 30 21.14±4.983 19.6 to 22.7 
p <0.0001 
After treatment 30 77.25±4.039 76 to 78.5 
 
 The mean± standard deviation of pain score at before and after treatment were 
21.14±4.983 and 77.25±4.039 respectively which is statistically considered extremely 
significant (p <0.0001).  
 
KOOS SCORE ASSESSMENT  BEFORE AND AFTER TREATMENT 
BETWEEN TWO GROUPS: 
 Sample 
size 
Mean±SD „t‟ value „p‟ value 
BT AT BT AT BT AT 
With 
varmam 
15 19.433±3.388 76.946±4.053 
1.993 0.4175 0.0561 0.6795 
Without 
varmam 
15 22.84±5.688 77.56±4.0029 
 
 There is no significant difference between with and without varmam treatment 
group. 
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HB AND RBC – INVESTIGATIONS BEFORE AND AFTER TREATMENT –
PATIENTS 
 
 
SL 
NO 
 
OP/IPNO 
 
NAME 
Hb gm% 
TRBC 
Million/cumm 
B.T A.T B.T A.T 
1 K08130 Sakthi valli 12 12.1 4.2 4.2 
2 I15391 Mohan 14.6 15 4.9 4.8 
3 K60982 Kavitha 16 16.1 5.4 5.3 
4 K96010 Muralikrishnan 13.6 13.6 4.4 4.2 
5 H02677 Ravichandran 11.3 11.3 4.3 4.4 
6 L02052 Sivakumar 11.5 12.2 4 4.1 
7 L03153 Sarava kumar 12.1 13.2 4.4 5.4 
8 5525 Maheshkumar 12.8 13.1 4.7 4.9 
9 F002104 Aruldoss 14.4 14.3 5.3 5.2 
10 L04732 K.Anand  15.3 16.1 5 4.5 
11 J18103 Ramani 11 12.3 4.7 4.1 
12 5556 Rajesh 14 14.2 4.4 4.6 
13 5565 Gokulnath 12.3 13.1 4.3 4.7 
14 K86778 Akshayashree 13.6 13.7 4.5 4.3 
15 L18268 Mathivanan 13.2 13.5 5.1 5 
16 K64880 Meenatchi 12.4 13.1 4.3 4.4 
17 L13330 Bhuvaneshwari 13.1 14.2 4.7 4.5 
18 K27997 Shakilabanu 13.2 13.5 4.9 4.8 
19 J63195 A.K.Singh 12.6 13.2 4.6 4.8 
20 L15438 Chandramohan 12.1 13.7 5.06 4.9 
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HB AND RBC – INVESTIGATIONS BEFORE AND AFTER TREATMENT –  
OPD PATIENTS 
 
SL.No 
OP/IP 
NO 
NAME 
Hb gm% 
TRBC 
Million/cumm 
B.T A.T B.T A.T 
21 K99836 A.Anand 13.2 13.5 4.9 4.5 
22 L08775 Pandey 13 13.4 4.5 4.7 
23 H47521 Nagaraj 13.1 13.4 4.6 4.4 
24 L08785 Natarajan 11.7 12.3 4.2 4.2 
25 L11402 A.Saravanan 12.3 13.4 4.7 4.9 
26 L03321 Rajesh 12.7 13.3 4.2 4.4 
27 L13877 Sasikala 15.5 15.8 6.6 6.8 
28 J31798 Gokila 10.3 11.1 4.7 4.6 
29 L22271 Jayanthi 14.6 15.3 5.1 5 
30 D098267 Kalaiselvi 13.3 13.6 4.9 4.6 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT- PATIENTS 
 
S. 
No 
IP /OP 
NO 
TC 
(million/ 
cu.mm) 
DC (%) ESR 
N L E Mxd ½ HR 1 HR 
BT AT BT A
T 
BT A
T 
B
T 
A
T 
B
T 
A
T 
B
T 
A
T 
B
T 
A
T 
1 K08130 5100 5200 57 61 34 33 - - 9 6 18 6 32 12 
2 I15391 6900 6800 69 72 26 24 - - 5 4 2 3 8 6 
3 K60982 6300 6400 60 66 35 32 - - 5 2 2 4 6 8 
4 K96010 4200 4400 40 56 53 39 - - 7 5 2 2 4 4 
5 H02677 9600 9800 63 67 33 31 - - 4 2 22 24 50 52 
6 L02052 7200 7600 58 62 36 34 - - 6 4 4 8 16 12 
7 L03153 5300 5600 56 63 39 31 - - 5 6 20 6 44 12 
8 5525 4800 5600 71 73 25 22 - - 4 5 24 10 50 20 
9 F002104 7200 7200 53 55 42 39 - - 5 6 6 3 12 6 
10 L04732 5600 5400 57 63 36 31 - - 7 6 6 4 12 8 
11 J18103 6400 6100 70 72 25 25 - - 5 3 22 10 46 14 
12 5556 5700 6200 60 65 36 29 - - 4 6 7 20 10 40 
13 5565 5600 5900 55 63 37 31 - - 8 6 6 3 12 6 
14 K86778 5600 5800 49 50 42 45 - - 9 5 22 12 44 24 
15 L18268 9600 7500 67 65 31 30 - - 2 5 2 2 6 4 
16 K64880 5400 5200 55 53 38 38 - - 7 9 10 5 20 10 
17 L13330 7700 7500 59 63 30 28 - - 11 9 32 12 68 24 
18 K27997 7500 7800 53 56 38 37 - - 9 7 2 2 4 4 
19 J63195 7100 7200 53 63 40 32 - - 7 5 6 3 12 6 
20 L15438 7200 8800 65 67 30 25 - - 5 8 4 2 18 8 
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BLOOD INVESTIGATIONS BEFORE AND AFTER TREATMENT- PATIENTS 
 
S.No 
IP /OP 
NO 
TC 
(million/ 
cu.mm) 
DC (%) ESR 
N L Mxd ½ HR 1 HR 
BT AT BT A
T 
BT AT B
T 
A
T 
BT A
T 
B
T 
AT 
21 K99836 7600 7400 58 59 38 36 4 5 2 2 6 6 
22 L08775 7000 7000 56 58 39 36 5 6 6 4 12 8 
23 H47521 5900 5400 74 62 50 34 3 4 8 6 16 12 
24 L08785 7900 7200 68 64 28 28 4 8 8 6 16 12 
25 L11402 9700 8600 55 58 41 0 4 3 22 8 58 18 
26 L03321 5300 5700 53 56 40 38 7 6 2 2 4 4 
27 L13877 8600 7700 52 53 41 40 6 7 2 2 4 4 
28 J31798 6700 7600 66 63 29 31 5 6 12 4 24 8 
29 L22271 5000 5700 60 63 32 29 8 8 2 2 6 6 
30 D098267 7600 8200 63 64 35 32 2 3 4 2 14 10 
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SERUM BILIRUBIN & GLUCOSE PROFILE 
BEFORE AND AFTER TREATMENT - PATIENTS 
 
S.No 
IP /OP 
NO 
Serum bilirubin (mg/dl) GLUCOSE 
PROFILE 
Direct Indirect Total FAST P.P. 
BT AT BT AT BT AT BT AT BT AT 
1 K08130 0.6 0.7 0.2 0.3 0.4 0.4 90 90 108 110 
2 I15391 0.7 0.7 0.2 0.2 0.5 0.5 88 92 121 118 
3 K60982 0.9 0.9 0.3 0.2 0.6 0.7 95 93 114 110 
4 K96010 0.9 1 0.3 0.4 0.6 0.6 91 98 112 118 
5 H02677 0.4 0.4 0.2 0.2 0.2 0.2 92 86 108 107 
6 L02052 0.6 0.6 0.4 0.3 0.2 0.3 103 96 123 110 
7 L03153 1.1 1 0.4 0.3 0.7 0.7 85 86 109 110 
8 5525 0.8 0.7 0.2 0.3 0.6 0.4 91 86 122 108 
9 F002104 0.6 0.6 0.2 0.3 0.4 0.3 81 91 121 112 
10 L04732 0.5 0.4 0.2 0.2 0.3 0.2 94 86 133 122 
11 J18103 0.5 0.6 0.2 0.3 0.3 0.3 78 84 118 110 
12 5556 0.5 0 0.2 0 0.4 0 96 0 120 0 
13 5565 0.6 0.7 0.2 0.1 0.4 0.5 81 18 104 106 
14 K86778 0.6 0.7 0.2 0.2 0.4 0.4 89 91 106 112 
15 L18268 0.7 0.7 0.2 0.2 0.5 0.4 82 83 101 111 
16 K64880 0.9 0.8 0.3 0.2 0.6 0.6 73 78 108 110 
17 L13330 0.8 0.7 0.2 0.2 0.6 0.5 76 78 112 110 
18 K27997 0.5 0.5 0.2 0.1 0.3 0.3 82 81 104 103 
19 J63195 0.8 0.8 0.2 0.1 0.6 0.4 95 97 108 110 
20 L15438 0.8 0.7 0.3 0.2 0.5 0.4 92 90 126 118 
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SERUM BILIRUBIN & GLUCOSE PROFILE 
BEFORE AND AFTER TREATMENT - PATIENTS 
 
S.No 
IP /OP 
NO 
Serum bilirubin (mg/dl) 
GLUCOSE 
PROFILE 
Direct Indirect Total FAST P.P. 
BT AT BT AT BT AT BT AT BT AT 
21 K99836 0.6 0.7 0.2 0.3 0.4 0.4 90 90 108 110 
22 L08775 0.7 0.7 0.2 0.2 0.5 0.5 88 92 121 118 
23 H47521 0.9 0.9 0.3 0.2 0.6 0.7 95 93 114 110 
24 L08785 0.9 1 0.3 0.4 0.6 0.6 91 98 112 118 
25 L11402 0.4 0.4 0.2 0.2 0.2 0.2 92 86 108 107 
26 L03321 0.6 0.6 0.4 0.3 0.2 0.3 103 96 123 110 
27 L13877 1.1 1 0.4 0.3 0.7 0.7 85 86 109 110 
28 J31798 0.8 0.7 0.2 0.3 0.6 0.4 91 86 122 108 
29 L22271 0.6 0.6 0.2 0.3 0.4 0.3 81 91 121 112 
30 D098267 0.5 0.4 0.2 0.2 0.3 0.2 94 86 133 122 
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LIVER FUNCTION TESTS BEFORE AND AFTER TREATMENT - PATIENTS 
 
S.No 
IP /OP 
NO 
SGOT 
(IU/dl) 
SGPT 
(IU/dl) 
Al.pho 
(U/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) 
T. 
Protein 
(g/dl) 
BT AT BT AT BT AT BT AT BT AT BT AT 
1 K08130 18 17 14 15 74 77 4.4 4.3 2 2.1 6.4 6.3 
2 I15391 21 20 19 20 93 95 4.9 4.1 2.6 2.5 7.5 7.3 
3 K60982 26 27 29 28 101 89 4.3 4.2 2.9 2.8 7.1 7 
4 K96010 25 80 30 23 74 96 4 3.5 2.8 3 6.8 6.5 
5 H02677 15 16 10 10 92 93 5 4.9 2.4 2.6 7.4 7.5 
6 L02052 16 18 9 12 83 87 4.6 4.6 2.7 2.7 7.6 7.6 
7 L03153 18 19 12 17 96 102 4.6 4.3 2.9 2.4 7.5 6.7 
8 5525 13 18 17 15 94 96 3.5 3.6 2.5 2.6 6 6.2 
9 F002104 19 0 21 0 106 0 4.3 0 2.3 0 6.6 0 
10 L04732 19 18 20 19 100 87 4 3.5 3 3 7 6.5 
11 J18103 15 18 8 16 80 93 4.1 4 2.5 2.4 6.6 6.4 
12 5556 15 18 8 16 86 93 4.1 4 2.5 2.4 6.6 6.4 
13 5565 22 24 28 26 110 97 4.1 4 2.1 2.1 6.2 6.1 
14 K86778 23 24 26 25 119 110 3.9 3.8 2.4 2.4 6.3 6.2 
15 L18268 36 33 37 31 98 87 4 4 2.1 2 6.1 6 
16 K64880 19 20 27 25 107 110 3.3 3.1 3 3 6.3 6.1 
17 L13330 17 22 14 18 79 86 5.0 4.5 2.1 2.3 7.1 6.8 
18 K27997 19 20 15 18 83 87 4.6 4.2 2.2 2.4 6.8 6.6 
19 J63195 18 19 16 14 86 97 4.3 4 3 3.1 7.3 7.1 
20 L15438 18 17 15 16 97 110 4.1 4 3.1 3.1 7.2 7.1 
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LIVER FUNCTION TESTS BEFORE AND AFTER TREATMENT – PATIENTS 
 
S.No 
IP /OP 
NO 
SGOT 
(IU/dl) 
SGPT 
(IU/dl) 
Al.pho 
(U/dl) 
Albumin 
(g/dl) 
Globulin 
(g/dl) 
T. 
Protein 
(g/dl) 
BT AT BT AT BT AT BT AT BT AT BT AT 
21 K99836 18 19 19 22 83 93 3.1 3.1 3.5 3.3 6.6 6.4 
22 L08775 14 20 16 18 19 110 4.1 4 2.5 2.4 6.6 6.4 
23 H47521 22 24 26 24 72 110 3.9 3.6 2.7 2.8 6.6 6.4 
24 L08785 14 19 10 14 79 107 4.6 4.4 2.9 2.8 7.4 7.2 
25 L11402 14 15 11 12 74 86 4.1 4.2 2.4 2.3 6.5 6.5 
26 L03321 18 18 14 14 99 96 4 4.1 2.1 2 6.1 6.1 
27 L13877 17 16 14 13 89 80 4.9 4.8 2.3 2.3 7.2 7.1 
28 J31798 19 18 24 24 87 96 4.1 4.1 3.4 3.2 7.5 7.3 
29 L22271 22 28 25 2.3 88 93 4.2 4.2 2.8 2.6 7 6.8 
30 D098267 16 15 19 18 91 96 4.2 4.1 2.8 2.7 7 6.8 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT 
PATIENTS 
 
S. 
NO 
IP /OP 
NO 
URINE 
Before Treatment After Treatment 
Albumin Sugar 
Deposits Albumin Sugar Deposits 
Pus 
Cells 
Epi. 
cells 
Pus 
Cells 
Epi. 
Cells 
1 K08130 NIL NIL NIL NIL NIL NIL NIL NIL 
2 I15391 NIL NIL NIL NIL NIL NIL NIL NIL 
3 K60982 NIL NIL NIL NIL NIL NIL NIL NIL 
4 K96010 NIL NIL NIL NIL NIL NIL NIL NIL 
5 H02677 NIL NIL NIL NIL NIL NIL NIL NIL 
6 L02052 NIL NIL NIL NIL NIL NIL NIL NIL 
7 L03153 NIL NIL NIL NIL NIL NIL NIL NIL 
8 5525 NIL NIL NIL NIL NIL NIL NIL NIL 
9 F002104 NIL NIL NIL NIL NIL NIL NIL NIL 
10 L04732 NIL NIL NIL NIL NIL NIL NIL NIL 
11 J18103 NIL NIL NIL NIL NIL NIL NIL NIL 
12 5556 NIL NIL NIL NIL NIL NIL NIL NIL 
13 5565 NIL NIL NIL NIL NIL NIL NIL NIL 
14 K86778 NIL NIL NIL NIL NIL NIL NIL NIL 
15 L18268 NIL NIL NIL NIL NIL NIL NIL NIL 
16 K64880 NIL NIL NIL NIL NIL NIL NIL NIL 
17 L13330 NIL NIL NIL NIL NIL NIL NIL NIL 
18 K27997 NIL NIL NIL NIL NIL NIL NIL NIL 
19 J63195 NIL NIL NIL NIL NIL NIL NIL NIL 
20 L15438 NIL NIL NIL NIL NIL NIL NIL NIL 
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URINE AND MOTIONS EXAMINATION BEFORE AND AFTER TREATMENT 
–PATIENTS 
 
 
 
S.NO IP /OP 
NO 
URINE 
Before Treatment After Treatment 
Albumin Sugar Deposits Albumin Sugar Deposits 
Pus 
Cells 
Epi. 
cells 
Pus 
Cells 
Epi. 
Cells 
21 K99836 NIL NIL NIL NIL NIL NIL NIL NIL 
22 L08775 NIL NIL NIL NIL NIL NIL NIL NIL 
23 H47521 NIL NIL NIL NIL NIL NIL NIL NIL 
24 L08785 NIL NIL NIL NIL NIL NIL NIL NIL 
25 L11402 NIL NIL NIL NIL NIL NIL NIL NIL 
26 L03321 NIL NIL NIL NIL NIL NIL NIL NIL 
27 L13877 NIL NIL NIL NIL NIL NIL NIL NIL 
28 J31798 NIL NIL NIL NIL NIL NIL NIL NIL 
29 L22271 NIL NIL NIL NIL NIL NIL NIL NIL 
30 D098267 NIL NIL NIL NIL NIL NIL NIL NIL 
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DISCUSSION 
 The main aim of the treatment was to study the safety and therapeutic Efficacy of 
the drug Vithu rasa mezhugu and Murivu ennai reduce pain, swelling, restriction of 
movements and other clinical symptoms in the disesae Muzhangal mootu savvu 
kayangal.  
 The clinical features of Muzhangal mootu savvu kayangal can be correlated with 
Knee joint-Ligament injury in modern science.Ligament injury-knee joint is an annoying 
and painful condition that limits the functions of the joints. There is a pain and 
tenderness in the knee joints during standing and walking.The four major ligaments in 
the knee , the anterior cruciate ligament and the medial collateral ligament are most often 
injured in sports. 
 The drugs which possess anti-Vaatha property as mentioned in Siddha literature 
were selected and the trial drugs were prepared  in the Gunapadam practical laboratory 
of  National Institute of Siddha, after getting proper authentication of raw drugs from the 
Medicinal botany department at NIS, Chennai 47, and Chemistry department in Siddha 
central Research Institute Arumbakkam Chennai 106, under the supervision of the 
members of the faculty members. The trial drug was prepared by the standard operating 
procedure as mentioned in the protocol. 
 The Biochemical qualitative and quantitative analysis were done at the 
Biochemistry lab of NIS. It revealed the presence of effective minerals. 
 The clinical study was conducted with a defined protocol and a proper proforma 
after the approval of the Institutional Ethical Committee. After screening patients 
reporting at the OPD of department of Sirappu Maruthuvam, 30 cases were selected for 
induction to the trial. Before enrollment into the trial the informed consent was obtained 
from the patients. 
            The patients were treated with trial drugs Vithu rasa mezhugu (internal) twice a 
day with Palm jiggery for 9 days andMurivuEnnai (external) for 48 days. Patients were 
instructed to take the medicines regularly advised to follow pathiyam (avoid tamarind, 
tubers, etc) and advised to avoid cold exposure.  
 After the treatment, the patients were advised to visit the Out-Patient ward of 
Department of Sirappu Maruthuvam for another 2 months for follow-up.  
 
93 
 
OBSERVATIONS: 
The majority affected sex is male (66.7%). The common cause for this is obesity, 
exposure to athletic activity and motor vehicular accidents. History taking these reveals 
the above reasons for male predominance. 
 This study shows that the highest incidence of Muzhangal mootu savvu kayangal  
is between 31-40 years of age. 
 In this study, 60% of cases were reported from Neithal land. In Siddha literatures, 
it was mentioned that Neithal, which is responsible for Vaatha diseases. This 
study also emphasized the same. 
 Among 30 patients, 25(83.3%) were non-vegetarians and 5 (16.7%) were 
vegetarians. 
 Munpani kaalam showed the highest incidence of 83.3% and 10% were reported 
during Kaar kaalam and 6.7% were reported during koothir kaalam. 
 Viyanan, Samanan were affected in all 30 cases. 
 In all the cases the Sathaga pitham was affected. 
 Santhigam was affected in all the 30 cases. Santhiga kabam mainly lives in joints 
and so it was affected in all the cases. 
 Pulse reading(Naadi) was observed in all patients.Among 30 cases, Before 
treatment, vaathapitham naadi was found in 8 patients, 21 were found in 
Pithavaatham and 1 had pithakabavatham. After treatement, vaathapitham naadi 
was found in 20 patients, 6 were found in Pithavaatham, 2 had pithakabam and 2 
had kabavaatham. 
 Out of 30 cases, Before treatment, in 50% of cases Neikkuri was found as 
Vaatham, 40% of cases found as pitham and 10% cases found as kabam. After 
treatment, in 33.33% of cases Neikkuri was found as Vaatham, 26.66% of cases 
found as pitham and 40% cases found as kabam. 
 Saaram and Oon were affected in all the 30 cases (100%), and there were no 
changes noted in other thathukkal like Enbu, Kozhupu, Moolai, Sukkilam and 
Suronitham. 
 Kaal was affected in all the 30 cases (100%). 
 
 
94 
 
LABORATORY INVESTIGATIONS: 
 By laboratory investigation ESR was found raised in 7 patients in early stages but 
after treatment it was found reduced. 
 Blood Urea and Serum Creatinine levels showed no changes in this study. 
 The MRI studies showed sprain and partial tear of knee joint ligaments. The trial 
drug showed improvement in prognosis of the disease clinically rather than in 
radiographic changes. 
THERAPEUTIC EFFICACY OF VITHU RASA MEZHUGU: 
 According to Koos score, The mean symptom assessment before treatment 
patients who treatedwithout varmam was 22.84 and after treatment it was increased to 
77.56. 
THERAPEUTIC EFFICACY OF VITHU RASA MEZHUGU ALONG WITH 
VARMAM: 
 15 patients are treated with Varmam along with the trial drug. The remaining 
15patients received only trial medicines. The results are compared at the end of the 
study. Inthis clinical trial, patients who treated with Varmam showed same result as it is 
in Without varmam patients. 
 The mean symptom assessment before treatment patients who treatedwith 
varmam was 19.433 and after treatment it was increased to 76.946. 
 
EVALUATION OF MEDICINES: 
 The Biochemical study revealed the presence of several minerals. The test drug 
answered for the presence of Phosphate, Ammonia, Ferrous iron, Tannic Acid,  
Alkaloids, Calcium, Mercury, Arsenic and Ammonium. 
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SUMMARY 
 The clinical study on Muzhangal mootu savvu kayangal with reference to its 
aetiology, pathogenesis, investigations, clinical features, diagnosis and treatment were 
conducted at the Sirappu maruthuvam Department, Ayothidoss Pandithar Hospital, 
National Institute of Siddha, Chennai – 47. 
 The study is conducted after approved by the Institutional Ethical Committee 
(IEC) and the trial was registered in Clinical trial registry of India 
(REF/2018/09/021429). Hence the study is safely executed on patients and there was no 
adverse drug reactions noted during the study period. 
 30 cases of both the sexes (majority of males) with the signs and symptoms of 
Muzhangal mootu savvu kayangal  were selected in the age group within 20 to 60 for the 
study. 15 were given Varmam therapy along with the trial drugs and for the remaining 15 
were given only the trial drugs for 48 days. Varmam therapy was given 3 alternative 
days in a week 
 All the details about the study and the drugs were informed to the patients in their 
vernacular language, dietary regimen and information sheet were given to them and 
signed consent forms were obtained from them. Before starting the treatment, the blood 
samples of the selected patients were subjected to investigation. 
 From the second day onwards, the patients were treated with the trial drugs Vithu 
rasa mezhugu 65mg bid with palm jaggery was given internally and Murivuennai 
externally. Every 8
th 
day; the patients were assessed for clinical improvement and 
adverse effects.  
 Before treatment and at the end of the treatment (49
th
 day) the laboratory 
investigations were done. The MRI of the affected Joints was taken. The improvement 
was assessed. 
 During the course of treatment there were no adverse effects or unwanted drug 
reactions in Gastro intestinal tract, Respiratory system, Cardio vascular system and 
excretorysystems. 
 15 patients are treated with varmam along with their trial medicine. The 
remaining 15 received only trail drugs. The results are compared at the end of the study. 
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The mean Koos score assessment before treatment was 19.433 and after treatment it was 
increased 76.946. 
  The study result was done in all the 30 patients participated in the trial using the Koos 
score. 
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CONCLUSION 
Varmam treatment along with the trial drugs showed sameimprovement as 
compared to the patients who were treated only with trial drug. Hence the study reveals 
the effectiveness of Trial drug intreatingMuzhangal mootu savvu kayangal. 
 Clinically, no adverse effects were reported during the trial and the 
laboratoryinvestigations were also within normal limits. So, the drug is assumed to be 
safe for human beings. 
 Hence the study concludes that, the trial drugs are clinically effective in reduction 
ofpain, swelling, restriction of movements.  
 However further work with large number of patients should be carried out 
towardsfinding the ideal dose response. 
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PRELIMINARY QUALITATIVE ANALYSIS OF DRUG – VITHU RASA 
MEZHUGU  
Preparation of Extract: 
 5gm of Vithu rasa mezhugu was weighed accurately and placed in a 250ml clean 
beaker and added with 50ml of distilled water. Then it is boiled well for about 10 
minutes. Then it is cooled and filtered in a 100ml volumetric flask and made up to 100ml 
with distilled water. 
S..No Procedure Observation Inference 
1. Test for Calcium: 
2 ml of extract is taken in a 
clean test tube. To this add 
2 ml of 4% ammonium 
oxide solution. 
 
Cloudy appearance 
and white precipitate 
is formed 
 
Presence of calcium 
2. Test for Sulphate:  
2 ml of the extract is added 
to 5 % barium chloride 
solution. 
 
No white precipitate 
is 
Formed 
 
Absence of  Sulphate 
3. Test for Chloride :  
The extract is treated with 
Silver nitrate solution 
No cloudy 
appearance present 
Absence  of Chloride 
4. Test for carbonate :  
The substance is treated 
with Conc. HCl. 
 
No effervescence is 
formed 
 
Absence of carbonate 
5. Test for Starch :  
The extract is added with 
weak iodine solution 
 
No blue color is 
formed 
 
Absence of starch 
6. Test for Iron (Ferric) : 
The extract is treated with 
glacial acetic acid and 
potassium ferrocyanide 
 
No blue color is 
formed 
 
Absence of Ferric 
iron 
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7. Test for Iron (Ferrous) : 
The extract is treated with 
Conc. HNO3 and 
ammonium thiocynate 
Blood red colour is 
formed 
Presence of Ferrous iron 
8. Test for phosphate : 
 The extract is treated with 
ammonium molybdate and 
conc. HNO3 
No Yellow precipitate is 
formed 
Absence of phosphate 
9. Test for Tannic acid: The 
extract is treated with Ferric 
chloride 
No Black precipitate is 
formed 
Absence of Tannic acid 
10. Test for Aluminium: 
To the 2m of the extract 
sodium hydroxide is added 
in drops to excess.  
No characteristic 
changes. 
Absence of aluminium. 
11. Test for Lead: 
2ml of the extract is added 
with 2ml of potassium 
iodide solution. 
No yellow precipitate is 
obtained. 
Absence of lead. 
12. Test for alkaloids:  
a. 2ml of the extract is 
treated wth 2,l of potassium 
Iodide olution. 
b. 2ml of extract is treated 
with 2 ml of picrid acid. 
 
c. 2ml of the extract is 
treated with 2ml of 
phosphotungstic acid. 
No red colour devloped 
 
 
 
Yellow colour 
developed 
 
No white precipitate is 
developed. 
 
     - 
 
 
Presence of Alkaloid 
 
   - 
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13. Test for Mercury: 
2ml of the extract is treated 
with 2ml of sodium 
hydroxide solution. 
 Yellow precipitate is 
obtained. 
 
Presence  of mercury. 
14. Test for Arsenic: 
2ml of the extract is treated 
2ml of sodium hydroxide 
solution. 
Brownish red 
precipitate is obtained. 
Presence of arsenic. 
15. Test for Ammonium: 
2ml of extract few ml of 
Nessler‟s reagent and 
excess of sodium hydroxide 
solution are added. 
Brown colour 
appeared. 
Presence of 
ammonium. 
16. Test for Magnesium: 
2ml of extract sodium 
hydroxide solution is added 
in drops to excess. 
White precipitate is 
obtained. 
Presence of  
Magnesium. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA MEZHUGU ” 
(INTERNAL) AND “MURIVU ENNAI” (EXTERNAL) IN THE TREATMENT OF 
“MUZHANGAL MOOTU SAVVU KAYANGAL” (LIGAMENT INJURY-KNEE JOINT). 
 
Principal Investigator: Dr.M.Monika 
 
FORM I - SCREENING & SELECTION PROFORMA 
 
1.SERIAL NO:      2. OP /IP NO:                 
3. NAME:            4. AGE/GENDER:  
5. OCCUPATION:      6. INCOME:  
 
INCLUSION CRITERIA 
 Whether age is 20 to 60 yrs      YES\NO 
 Sex         M\F 
 Pain and tenderness , often sudden and severe in the knee joint YES\NO 
 Pain gets worsen while walking     YES\NO 
 Swelling present in the knee joint     YES\NO 
 A feeling of looseness in the knee joint    YES\NO 
 Inability to put weight on the joint without pain   YES\NO 
 Patient willing to undergo radiological investigation   YES\NO 
 Patient willing to undergo laboratory investigations   YES\NO 
 Patients willing to sign the informed consent stating 
that he/she will conscientiously stick to the treatment  
during 48 days but can opt out of the trial of his/her own conscious 
discretion        YES\NO 
 
EXCLUSION CRITERIA 
 Posterior cruciate ligament tear     YES\NO 
 Complete tear of the ligament      YES\NO 
 H/O cardiac disease       YES\NO 
 H/O Rheumatoid disease      YES\NO 
 H/O Chronic kidney disease      YES\NO 
 Pregnancy and lactation      YES\NO 
 Septic arthritis        YES\NO 
 Gonococcal arthritis       YES\NO 
 Psoriatic arthritis       YES\NO 
 Patient with any other serious systemic illness   YES\NO  
 
 
ADMITTED TO TRAIL 
YES  NO  
If Yes, OPD  IPD  
  Serial NO:  
 
Date    :   
Station : 
Signature of the Investigator : 
Signature of the Lecturer :                                             Signature of the HOD   
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA MEZHUGU” (INTERNAL) 
AND „MURIVU ENNAII” (EXTERNAL) IN THE TREATMENT OF “MUZHANGAL MOOTU SAVVU 
KAYANGAL ” (LIGAMENT INJURY-KNEE JOINT). 
Principal Investigator : Dr.M.Monika 
 
STUDY  NO:   OP / IP NO: 
NAME: AGE / GENDER: 
ADDRESS: CONTACT NO : 
 RELIGION :  H / C / M / O. 
OCCUPATION: INCOME: 
MARITAL STATUS :       1. Married 2. Unmarried 
DATE OF INTIAL ASSESSMENT:  
COMPLAINTS & DURATION:   
 
FORM II-A–HISTORY TAKING PROFORMA 
                                                                                                                                                                              
PERSONAL HISTORY: 
PERSONAL HABITS YES NO 
IF YES 
SPECIFY 
DURATION 
AMOUNT/Qty 
Smoking     
Tobacco Chewing     
Alcohol     
Narcotic  Drug Addiction     
 
HISTORY OF PREVIOUS ILLNESS AND TREATMENT TAKEN: 
 
FAMILY HISTORY: 
Whether this problem runs in family? 1. Yes            2. No    
If yes, mention the relationship of affected 
person(s) 
1._________________ 
 
2._________________ 
 
DIETARY STYLE: 1. Vegetarian    2. Non-vegetarian 
 
 
MENSTURAL AND OBSTETRIC HISTORY: 
 
  
 
 
 
 
 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
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FORM –II B 
 
GENERAL EXAMINATION: 
1. Body weight [Kg]    :                      
2. Height [cms]                       :                        
3. Body Temperature [F]       :   
4. Blood Pressure (mm/Hg)  :      
5. Pulse Rate /min.   : 
6. Heart Rate / min.    : 
7. Respiratory Rate /min.  :   
Yes            No   
8. Pallor   :   
9. Jaundice   :   
10. Clubbing   : 
11. Cyanosis   : 
12. Pedal Oedema   : 
13. Lymphadenopathy      :  
14. Jugular venous pulsation  :   
SYSTEMIC EXAMINATION 
  Cardiovascular system  :  
  Respiratory system   :  
  Gastro-intestinal system  :  
  Central Nervous system  :  
  Urogenital system   :  
Endocrine system  :  
SIDDHA SYSTEM OF EXAMINATION 
1. THEGI (BODY CONSTITUTION): 
1. Vatha udal 
2. Pitha udal 
3. Kaba udal 
4. Thontha udal 
2. NILAM (LAND WHERE THE PATIENT LIVED MOST):  
1. Kurinji (Hilly terrain) 
2. Mullai (Forest range) 
3. Marutham (Plains) 
4. Neithal (Coastal belt) 
5. Paalai (Aridregion) 
3. KAALAM: 
1. Kaar kaalam    (Aavani-Purattasi) 
2. Koothir kaalam     (Ippasi-Kaarthigai) 
3. Munpani kaalam     (Maargazhi-Thai) 
4. Pinpani kaalam       (Maasi-Panguni) 
5. Ilavenil kaalam        (Chithirai-Vaigasi) 
6. Muthuvenil kaalam (Aani-Aadi) 
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4. GUNAM: 
1. Sathuvam  
2. Rasatham 
3. Thamasam 
 
 
5. PORIPULANGAL (SENSORY ORGANS):          
 
 
 
 
 
 
 
 
 
6.KANMENDRIYAM (MOTOR ORGANS) : 
 
 
 
 
 
 
 
 
7.KOSANGAL (SHEATH):           
 
 
 
 
 
 
  
 
 
 
  
 
 
 
 
 Before treatment After treatment 
Mei (Skin)  
Normal  / Affected 
 
Normal  / Affected 
Vai (Tongue)  
Normal  / Affected 
 
Normal  / Affected 
Kann (Eye)  
Normal  / Affected 
 
Normal  / Affected 
Mooku (Nose)  
Normal  / Affected 
 
Normal  / Affected 
 
Sevi (Ear)  
Normal  / Affected 
 
Normal  / Affected 
 Before treatment After treatment 
Kai(Upper limb)  
Normal  /Affected 
 
Normal  /Affected 
Kaal (Lower limb)  
Normal  /Affected 
 
Normal  /Affected 
Vai (Oral cavity)  
Normal  /Affected 
 
Normal  /Affected 
Eruvai (Anal reg.)  
Normal  /Affected 
 
Normal  /Affected 
Karuvai (Uro-
genital region) 
 
Normal  /Affected 
 
Normal  /Affected 
 Before treatment After treatment 
Annamaya kosam  
Normal  /Affected 
 
Normal  /Affected 
Pranamaya kosam   
Normal  /Affected 
 
Normal  /Affected 
Manomaya kosam   
Normal  /Affected 
 
Normal  /Affected 
Vignanamaya kosam   
Normal  /Affected 
 
Normal  /Affected 
Ananthamaya kosam  
Normal  /Affected 
 
Normal  /Affected 
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8.  SEVEN UDAL THAATHUKKAL (SEVEN SOMATIC COMPONENTS) 
 
 Before treatment After treatment 
 
Saaram 
 
Normal  /Affected 
 
Normal  /Affected 
 
Senneer  
 
Normal  /Affected 
 
Normal  /Affected 
 
Oon 
 
Normal  /Affected 
 
Normal  /Affected 
 
Kozhuppu 
 
Normal  /Affected 
 
Normal  /Affected 
 
Enbu 
 
Normal  /Affected 
 
Normal  /Affected 
 
Moolai 
 
Normal  /Affected 
 
Normal  /Affected 
 
Sukkilam / Suronitham 
 
Normal  /Affected 
 
Normal  /Affected 
 
9. UYIR THAATHUKKAL: [THREE HUMORS] (VALI/ AZHAL/ IYYAM) 
 
A) VALI 
 
 
0
th
  
day 
8
th
 
day 
15
th
  
day 
22
nd
 
day 
29
th
 
day 
36
th
 
day 
43
rd
 
day 
49
th
 
day 
Praanan         
Abaanan         
Samaanan         
Udhaanan         
Viyaanan         
Naagan         
Koorman         
Kirukaran         
Devathathan         
Dhananjeyan         
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B) AZHAL 
 
 
0
th
  
day 
8
th
  
day 
15
th
  
day 
22
nd
  
day 
29
th
  
day 
36
th
  
day 
43
rd
  
day 
49
th
  
day 
Analakam         
Ranjakam          
Saathakam          
Prasakam          
Aalosakam         
 
 
 
 
C) IYYAM 
 
 
0
th
  
day 
8
th
  
day 
15
th
  
day 
22
nd
  
day 
29
th
  
day 
36
th
  
day 
43
rd
  
day 
49
th
  
day 
Avalambagam         
Kilethagam         
Pothagam         
Tharpagam         
Santhigam         
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10. ENVAGAI THERVU: [EIGHT TYPES OF EXAMINATION] 
 
I. NAADI: [PULSE PERCEPTION] 
 
NAADI 
0
th
   
day 
8
th  
day
 
15
th  
day 
22
nd 
day 
29
th 
day 
36
th
   
day 
43
rd 
day 
49
th 
day 
         
 
II. SPARISAM: [PALPATION] 
 
Day SPARISAM 
0
th
  day  
8
th 
day
  
15
th
  day  
22
nd
  day  
29
th
  day  
36
th
  day  
43
rd
 day  
49
th 
day  
 
 
 
 
 
III. NAA: [TONGUE] 
 
NAA 0
th
day 8
th
day
 
15
th
day 22
nd
day 29
th
day 36
th
day 43
rd
day 49
th
day 
         
 
 
IV.NIRAM: [COMPLEXION]   
 1. Vadham         
 2. Pitham 
 3. Kabam 
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V.MOZHI: [VOICE] 
1. High Pitched 
2. Low Pitched 
3. Medium Pitched 
 
 
VI.VIZHI: [EYES] 
VIZHI 0
th
  day 8
th 
day
 
15
th
day 22
nd
day 29
th
day 36
th
  day 43
rd
day 49
th
day 
         
 
 
VII. MALAM: [BOWEL HABITS / STOOLS] 
 
 Before treatment After treatment 
Niram   
Irugal   
Ilagal   
Others   
 
 
 
VIII. MOOTHIRAM [URINE EXAMINATION]  
NEERKKURI: 
 
Neerkkuri Before treatment After treatment 
Niram   
Manam   
Edai   
Nurai   
Enjal   
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NEIKKURI:  
 
Neikkuri Before treatment After treatment 
 Aravena neendathu/ 
Snake like pattern 
 
  
Aazhipol paraviyathu 
Annular/Ringedpattern 
 
 
 
parav 
paraparavoiyadu 
  
Muththothu ninrathu  
Pearlbeadepattern 
  
Other p tterns   
 
CLINICAL EXAMINATION :        
 
LOCOMOTOR SYSTEM : 
 CLINICAL SYMPTOMS : 
Affected knee joint: Right Left    Both               
Pain and stiffness 
 in knee joint: Mild Moderate   Severe 
Onset:                             Sudden                   Gradual 
CLINICAL EXAMINATION  
I.INSPECTION: 
 0
th
 day 8
th
 day 15
th
 day 22
nd
day 29
th
 day 36
th
 day 43
rd
day 49
th
 day 
Swelling         
Stiffness  
 
 
      
Gait         
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II.PALPATION: 
 0
th
 day 8
th
 day 
15
th
 
day 
22
th
 
day 
29
th
 day 36
th
 day 43
rd
day 49
th
 day 
Tenderness         
Local heat         
III. MOVEMENTS 
 0
th
 day 8
th
 day 
15
th
 
day 
22
nd
day 29
th
 day 36
th
 day 43
rd
day 49
th
 day 
Flexion          
Extension          
 
IV. JOINT MESUREMENT: 
A. HEALTH ASSESSMENT QUESTIONNAIRE: 
 
0
th
  
day 
8
th
  
day 
15
th
  
day 
22
nd 
day 
29
th
 
day 
36
th
 
day 
43
rd 
day 
49
th
 
day 
PAIN 
A. Onset: 
Sudden/Gradual 
 
        
B. Early morning  
Stiffness 
(Present/absent) 
        
C. Nature of pain                                             
(Mild/ Moderate/ 
Severe) 
        
D. Aggravating   
factor- 
Movement  
(Yes/No) 
        
E. Relieving factor 
–Rest 
(Yes/No) 
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KNEE JOINT LIGAMENT EXAMINATION: 
1. Anterior drawer sign: 
The anterior drawer test examine for any tearing or laxity of the anterior cruciate 
ligament. 
2. Posterior drawer test: 
The posterior drawer test is used to examine the posterior cruciate ligament. 
3. Valgus test: 
The valgus stress test checks for medial joint laxity , which usually represents an 
injury to the medial collateral ligament. 
4. Varus test: 
The varus stress test checks for joint laxity on the outside of the knee , which 
usually represents an injury to the lateral collateral ligment. 
5. McMurray‟s test: 
This test checks for meniscal tears and other internal derangement in the knee. 
OUTCOME: 
Primary outcome: 
Primary outcome of the study is pain relieving and it will be assessed by the 
following methods:  
WOMAC - How to score from the KOOS 
Assign scores from 0 to 4 to the boxes as shown above. To get original WOMAC 
Scores, sum the item scores for each subscale. If you prefer percentage scores in 
accordance with the KOOS, use the formula provided below to convert the original 
WOMAC scores. 
 
 
 
 
G. Tenderness 
(Present/absent) 
        
RESTRICTION 
OF MOVEMENT  
(Fully/Partial/No) 
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Transformed scale = 100 - actual raw score x 100   
  maximum score   
  
 
  
WOMAC subscores Original score = sum of Maximum score 
  the following items   
Pain P5-P9 20 
Stiffness S6-S7 8 
Function A1-A17 68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date:          
Station: 
 
 
Signature of the Investigator: 
Signature of the Lecturer:                                                         Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA 
MEZHUGU” (INTERNAL) AND “MURIVU ENNAI ” (EXTERNAL) IN THE 
TREATMENT OF “MUZHANGAL MOOTU SAVVU KAYANGAL” (LIGAMENT 
INJURY-KNEE JOINT). 
 
Principal Investigator: Dr.M.Monika 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Blood 
glucose 
(mg/dl) 
Fasting 70-110   
PP 80-140   
RFT 
(mg/dl) 
Blood urea 16-50   
Serum creatinine 0.6-1.2   
LFT 
(mg/dl) 
Total bilirubin 0.2-1.2   
Direct bilirubin 0.1-0.2   
Indirect bilirubin 0.2-0.7   
Total protein 6-8   
Serum Albumin 3.5-5.5   
Serum globulin 2-3.5   
SGOT (IU/L) 0-40   
SGPT (IU/L) 0-35   
Alkaline phosphatase 
(IU/L) 
80-290   
 
Serum calcium 9-11   
Serum phosphorus 2-5   
Serum Uric acid 
M:3-9 
W: 2.5-7.5 
  
 CRP   
 ASO titre   
 RA factor   
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1.SERIAL NO:      2. OP /IP NO:                 
3. NAME:            4. AGE/GENDER: 
 
FORM-III - LABORATORY INVESTIGATIONS 
 
BLOOD INVESTIGATIONS 
NORMAL 
VALUES 
BEFORE 
TREATMENT 
AFTER 
TREATMENT 
Hb( gm/dl) 
M:13-18 
W:11-16 
  
T.RBC(millions cells /Cu.mm) 
M:4.5-6.5 
W:3.5-5.5 
  
ESR (mm) 
½ hr. -   
1 hr. 
M:0-10 
W:0-20 
  
T.WBC (Cells /Cu.mm) 4000-11000   
Differential 
Count (%) 
Polymorphs 40-75   
Lymphocytes 20-35   
Monocytes 2-10   
Eosinophils 1-6   
Basophils 0-1   
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B.URINE INVESTIGATIONS: 
URINE 
INVESTIGATIONS 
BEFORE TREATMENT 
AFTER 
TREATMENT 
Albumin   
Sugar (Fasting) 
    (PP) 
  
Deposits   
Bile salts   
Bile pigments   
 
C.RADIOLOGICAL EXAMINATIONS 
MRI-KNEE JOINT 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Date:          
Station: 
 
Signature of the Investigator: 
Signature of the Lecturer:                                                         Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA MEZHUGU” 
(INTERNAL) “MURIVU ENNAI” (EXTERNAL) IN THE TREATMENT OF   
“MUZHANGAL MOOTU SAVVU KAYANGAL” WITH VARMA. 
Name of Principal Investigator: Dr.M.Monika      
FORM –IV- DRUG COMPLIANCE FORM 
SERIAL NO: 
NAME:  
DRUG NAME:  
On 1
st    
 day-Date:  Drugs issued: (mgs) Drugs returned:    (mgs) 
On 8
th
   day-Date:   Drugs issued: (mgs) Drugs returned:    (mgs) 
On 15
th
 day-Date:              Drugs issued: (mgs) Drugs returned:    (mgs) 
On 22
th
 day-Date:           Drugs issued: (mgs) Drugs returned:    (mgs) 
On 29
th
 day-Date:             Drugs issued: (mgs) Drugs returned:    (mgs) 
On 36
th
 day-Date:              Drugs issued: (mgs) Drugs returned:    (mgs) 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                           Signature of the HOD 
   Day    Date          Morning   Evening   Day    Date    Morning   Evening 
Day 1    Day25    
Day2    Day26    
Day3    Day27    
Day4    Day28    
Day5    Day29    
Day6    Day30    
Day7    Day31    
Day8    Day32    
Day9    Day33    
Day10    Day34    
Day11    Day35    
Day12    Day36    
Day13    Day37    
Day14    Day38    
Day15    Day39    
Day16    Day40    
Day17    Day41    
Day18    Day42    
Day19    Day43    
Day20    Day44    
Day 21    Day45    
Day 22    Day46    
Day 23    Day47    
Day 24    Day48    
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA MEZHUGU” 
(INTERNAL) AND “MURIVU ENNAI” (EXTERNAL) IN THE TREATMENT OF   
“MUZHANGAL MOOTU SAVVU KAYANGAL” (LIGAMENT INJURY-KNEE JOINT) 
WITH AND WITHOUT VARMAM.      
FORM-V–INFORMATION SHEET 
 
Name of Principal Investigator    :Dr .M.Monika 
Name of the institute                   : National Institute of Siddha, 
Tambaram Sanatorium, 
Chennai-47. 
INFORMATION SHEET FOR PATIENTS PARTICIPATING IN THE OPEN 
CLINICAL TRIAL: 
I, Dr.M.Monika Studying as M.D(Siddha) at National Institute of  Siddha, 
Tambaram Sanatorium is doing a trial on the study of Muzhangal Mootu Savvu 
Kaayangal (Ligament injury-knee joint). In this regard, I am in a need to ask you few 
questions. I will maintain confidentiality of your comments and data obtained. There will 
be no risk of disclosing your identity and no physical, psychological or professional risk 
is involved by taking part in this study. Taking part in this study is voluntary. No 
compensation will be paid to you for taking part in this study. 
           You can choose not to take part. You can choose not to answer a specific 
question. There is no specific benefit for you if you take part in the study. However, 
taking part in the study may be of benefit to the community, as it may help us to 
understand the problem of defaulters and potential solutions. 
             If you agree to be a participant in this study, you will be included in the study 
primarily by signing the consent form and then you will be given the internal medicine 
Vithu rasa mezhugu(Internal medicine- Twice a Day with palm jaggery for 9 days) and 
Murivu ennai  (External medicine), if you wish to stay in the In Patient ward varmam 
Treatment will be provided to you assuring that you will not be definitely hurt in any 
course of treatment. 
 The information I am collecting in this study will remain between you and the 
principal investigator (myself). If you wish to find out more about this study before 
taking part, you can ask me all the questions you want or contact Dr.M.Monika, PG 
Scholar cum principal investigator of this study,attached to National Institute of 
Siddha,Chennai-47. You can also contact the Member-secretary of Ethics committee, 
National Institute Siddha,Chennai 600047,  for rights and participation in the study 
. 
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¾¸Åø  ÀÊÅõ 
  
§¿¡öì¸¡É º¢ò¾ ÁÕóÐ¸Ç¢ý Å¢òÐ Ãº ¦ÁØÌ (¯û ÁÕóÐ) ÁüÚõ 
ÓÈ¢ ¦Åñ¦½ö (¦ÅÇ¢ ÁÕóÐ) ÀÃ¢¸Ã¢ôÒò ¾¢È¨Éì ¸ñ¼È¢Ôõ ÁÕòÐÅ 
¬öÅ¢ü¸¡É ¾¸Åø ÀÊÅõ. 
 
Ó¾ý¨Á ¬Ã¡öîº¢Â¡Ç÷ ¦ÀÂ÷ : Ó. §Á¡É¢¸¡ 
 
 
¿¢ÚÅÉò¾¢ý ¦ÀÂ÷            :   §¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉõ 
    ¾¡õÀÃõ º¡Éð§¼¡Ã¢Âõ 
    ¦ºý¨É- 47 
 
§¾º¢Â º¢ò¾ ÁÕòÐÅ ¿¢ÚÅÉò¾¢ø Àð¼ §ÁüÀÊôÒ ÀÂ¢ýÚ ÅÕõ ¿¡ý   
(ÁÕòÐÅ÷.Ó.§Á¡É¢¸¡) ÓÆí¸¡ø ãðÎ ºù× ¸¡Âí¸û ±ýÛõ §¿¡öì¸¡É 
ÁÕòÐÅ ¬Ã¡öîº¢Â¢ø ®ÎÀðÎû§Çý. 
 þÐ §¾¡ûÀð¨¼Â¢ø ÅÄ¢, Å¢¨ÈôÒò¾ý¨Á, ¨¸¨Â ¿£ð¼ Á¼ì¸ 
ÓÊÂ¡Áø §¿¡¾ø Ó¾Ä¢Â ÌÈ¢Ì½í¸¨Çì ¦¸¡ñ¼ §¿¡ö 
þÐ ÀÃÅì ÜÊÂ §¿¡ö «øÄ. þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ º¢Ä 
§¸ûÅ¢¸¨Çì §¸ð¸×õ, §¾¨ÅÂ¡É ¬öÅ¸ ÀÃ¢§º¡¾¨ÉìÌ ¾í¸¨Ç 
¯ðÀÎò¾×õ ¯û§Çý. þó¾ ¬Ã¡öîº¢ìÌ ¾¡í¸û Å¢ÕôÀò¾¢ý §ÀÃ¢ø ¯ðÀÎõ 
Àðºò¾¢ø ¯ûÁÕó¾¡¸ Å¢òÐ Ãº ¦ÁØÌ 65mg ¦Åó¿£¡¢ø 2 §Å¨Ç  (¸¡¨Ä 
Á¡¨Ä) ¯½×ìÌô À¢ý 9 ¿¡ð¸ÙìÌ ¯ð¦¸¡ûÇ §ÅñÎõ. ¦ÅÇ¢ ÁÕó¾¡¸ 
ÓÈ¢¦Åñ¦½ö 48 ¿¡ð¸ÙìÌ §¿¡ÔûÇ þ¼í¸Ç¢ø ¦ÅÇ¢§Â ¾¼Å §ÅñÎõ. 
¦ÅÇ¢ §¿¡Â¡Ç÷ 7 ¿¡ð¸ÙìÌ ´ÕÓ¨È ÁÕòÐÅÁ¨ÉìÌ ÅÃ§ÅñÎõ. 
þÐ ºõÀó¾Á¡É ¾í¸ÇÐ «¨ÉòÐ Å¢ÅÃí¸Ùõ Ã¸º¢ÂÁ¡¸ ¨Åì¸ôÀÎõ 
±É ¯Ú¾¢ «Ç¢ì¸¢§Èý. þ¾¢ø ÀÂ½ôÀÊ Ó¾Ä¢Â ±ó¾ ¯¾Å¢ ¦¾¡¨¸Ôõ 
ÅÆí¸ôÀ¼ Á¡ð¼¡Ð. þó¾ ¬Ã¡öîº¢Â¢ý §À¡Ð ¯¼ÖìÌ §ÅÚ À¡¾¢ôÒ ²üÀÎõ 
Àðºò¾¢ø §¾º¢Â º¢ò¾ ÁÕòÐÅÁ¨ÉÂ¢ø ¾ì¸ Á¡üÚ º¢¸¢î¨º «Ç¢ì¸ôÀÎõ.  
þó¾ ¬Ã¡öîº¢Â¢ø ¾í¸¨Ç ¯ðÀÎò¾¢Â À¢ÈÌ ¯í¸ÙìÌ Å¢ÕôÀÁ¢ø¨Ä¦ÂÉ¢ø 
±ô§À¡Ð §ÅñÎÁ¡É¡Öõ Å¢Ä¸¢ ¦¸¡ûÇ ÓØ ¯Ã¢¨Á ¯ûÇÐ. 
þó¾ ¬Ã¡öîº¢ ºõÀó¾Á¡¸ ÁüÈ Å¢ÀÃí¸ÙìÌõ §¿¡Â¢ý ¾ý¨Á ÀüÈ¢Ôõ  
Ó¾ý¨Á ¬Ã¡öîº¢Â¡ÇÃ¡É ÁÕ.Ó.§Á¡É¢¸¡ (Àð¼ §Áü ÀÊôÀ¡Ç÷ 
º¢ÈôÒÁÕòÐÅ À¢Ã¢×) «Ï¸×õ. §ÁÖõ þó¾ ¬Ã¡öîº¢ìÌ IEC º¡ýÚ 
¦ÀÈôÀðÎûÇÐ. 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA MEZHUGU” 
(INTERNAL) AND “MURIVU ENNAI” (EXTERNAL) IN THE TREATMENT OF   
“MUZHANGAL MOOTU SAVVU KAYANGAL” (LIGAMENT INJURY-KNEE JOINT) 
WITH AND WITHOUT VARMAM.  
Name of Principal Investigator: Dr.M.Monika.     
 
FORM-VI – CONSENT FORM 
 
 
“I have read the foregoing information, or it has been read to me. I have had 
the opportunity to ask questions about it and any questions I have asked have been 
answered to my satisfaction.  
            I consent voluntarily to participate as a participant in this study and 
understand that I have the right to withdraw from the study at any time without in any 
way it affecting my further medical care”. 
 
"I have received a copy of the information sheet/consent form". 
 
Date:  
Signature of the participant 
In case of illiterate participant 
 
        “I have witnessed the accurate reading of the consent form to the potential 
participant, and the individual has had the opportunity to ask questions. I confirm 
individual has given consent freely.”                                                  s 
 
 
Date: 
 
 
Signature of a witness  
(Selected by the participant bearing no connection with the survey team)  
       
 
 
 
 
 
 
Left thumb Impressionof the Participant 
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FORM –VI  ´ôÒ¾ø ÀÊÅõ 
¬öÅ¡ÇÃ¡ø º¡ýÈÇ¢ì¸ôÀð¼Ð 
¿¡ý ÓÆí¸¡ø ãðÎ ºù× ¸¡Âí¸û±ýÛõ §¿¡Â¢ý ¬ö¨Åì ÌÈ¢ò¾ 
«¨ÉòÐ Å¢ÀÃí¸¨ÇÔõ §¿¡Â¡Ç¢ìÌô ÒÃ¢Ôõ Å¨¸Â¢ø ±ÎòÐ¨Ãò§¾ý ±É 
¯Ú¾¢ÂÇ¢ì¸¢§Èý. 
 
§¾¾¢:                                      ¨¸¦Â¡ôÀõ: 
 
þ¼õ:                 ¦ÀÂ÷:   
 
§¿¡Â¡Ç¢Â¢ý ´ôÒ¾ø 
±ýÉ¢¼õ  þó¾  ÁÕòÐÅ  ¬öÅ¢ý  ¸¡Ã½ò¨¾Ôõ,  ÁÕó¾¢ý ¾ý¨Á  
ÁüÚõ ÁÕòÐÅ  ÅÆ¢Ó¨È  ÀüÈ¢Ôõ, ¦¾¡¼÷óÐ  ±ÉÐ  ¯¼ø  þÂì¸ò¨¾ì  
¸ñ¸¡½¢ì¸×õ, «¾¨Éô  À¡Ð¸¡ì¸×õ  ÀÂýÀÎõ  ÁÕòÐÅ  ¬ö×ìÜ¼  
ÀÃ¢§º¡¾¨É¸û  ÀüÈ¢  ¾¢Õô¾¢ «Ç¢ìÌõ  Å¨¸Â¢ø  ¬ö×  ÁÕòÐÅÃ¡ø  
Å¢Çì¸¢ì  ÜÈôÀð¼Ð. 
¿¡ý þó¾ ÁÕòÐÅ ¬öÅ¢ý §À¡Ð, ±ô¦À¡ØÐ §ÅñÎÁ¡É¡Öõ  þó¾  
¬öÅ¢Ä¢ÕóÐ   ±ý¨É Å¢ÎÅ¢òÐ  ¦¸¡ûÙõ  ¯Ã¢¨Á¨Âò 
¦¾Ã¢ó¾¢Õì¸¢ý§Èý. 
 ¿¡ý ±ýÛ¨¼Â Í¾ó¾¢ÃÁ¡¸ò §¾÷× ¦ºöÔõ ¯Ã¢¨Á¨Âì ¦¸¡ñÎ 
ÓÆí¸¡ø ãðÎ ºù× ¸¡Âí¸û §¿¡öì¸¡É Å¢òÐÃº ¦ÁØÌ (¯û ÁÕóÐ) 
ÁüÚõ ÓÈ¢¦Åñ¦½ö (¦ÅÇ¢ ÁÕóÐ) ÁÕó¾¢ý ÀÃ¢¸Ã¢ôÒò  ¾¢È¨Éì  
¸ñ¼È¢Ôõ ÁÕòÐÅ ¬öÅ¢üÌ ±ý¨É  ¯ðÀÎò¾ ´ôÒ¾ø «Ç¢ì¸¢§Èý. 
 
§¾¾¢:                                ¨¸¦Â¡ôÀõ: 
þ¼õ:         ¦ÀÂ÷:   
º¡ðº¢ì¸¡Ã÷ ¨¸¦Â¡ôÀõ: 
¦ÀÂ÷: 
¯È×Ó¨È:             
Å¢Ã¢×¨ÃÂ¡Ç÷    ¨¸¦Â¡ôÀõ:                           Ð¨Èò¾¨ÄÅ÷ ¨¸¦Â¡ôÀõ 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
 DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHURASA 
MEZHUGU”(INTERNAL) AND “MURIVU ENNAI” (EXTERNAL) IN THE TREATMENT 
OF   “MUZHANGAL MOOTU SAVVU KAYANGAL”(LIGAMENT INJURY-KNEE 
JOINT) WITH AND WITHOUT VARMAM. 
Name of Principal Investigator: Dr.M.Monika      
 
FORM VII -WITHDRAWAL FORM 
 
1. SERIAL NO OF THE CASE:  
2. OP / IP NO:   
3. NAME:   
4. AGE:  
5. GENDER: 
6. DATE OF TRIAL COMMENCEMENT:  
7. DATE OF WITHDRAWAL FROM TRIAL:  
8. REASONS FOR WITHDRAWAL: 
Long absence at reporting:               Yes/ No 
Irregular treatment:                           Yes/ No 
Shift of locality:                                     Yes/No 
Increase in severity of symptoms:     Yes/No 
Development of severe adverse drug reactions:   Yes/No 
Development of adverse event:                                            Yes/No 
(If YES, give the details of adverse reaction in Form VII -B – Adverse      
Reaction Form / Pharmaco Vigilance Form) 
 
 
 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                         Signature of the HOD 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
DEPARTMENT OF SIRAPPU MARUTHUVAM 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHURASA MEZHUGU” 
(INTERNAL) AND “MURIVENNAI” (EXTERNAL) IN THE TREATMENT OF 
“MUZHANGAL MOOTU SAVVU KAYANGAL” (LIGAMENT INJURY – KNEE 
JOINT)” WITH AND WITHOUT YOGAM. 
Name of Principal Investigator: Dr.M.Monika    
 
FORM VII - A – ADVERSE REACTION FORM / PHARMACO VIGILANCE 
FORM 
 
SERIAL NO:                                                                                                           
OP/IP NO: 
NAME:                                                             AGE:                     GENDER: 
DATE OF TRIAL COMMENCEMENT: 
DATE OF THE ADVERSE REACTION OCCUR: 
DESCRIPTION OF ADVERSE REACTION: 
 
 
 
 
 
 
 
 
 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                            Signature of the HOD 
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FORM VII- PHARMACOVIGILANCE/WITHDRAWAL FORM 
1. Patient / consumer identification (please complete or tick boxes below as 
appropriate) 
NATIONAL PHARMACOVIGILANCE PROGRAMME FOR  SIDDHA DRUGS 
 
 
Please note:  i.All consumers / patients and reporters information will remain 
confidential. 
         ii. It is requested to report all suspected reactions to the concerned, 
even if it does not have complete data, as soon as possible. 
Peripheral Center code:     State: 
Name  Father name Patient / Record 
No. Ethnicity  Occupation 
Address  
Village / Town 
Post / Via 
District / State   
Date of Birth / 
Age: 
Sex:     M / F 
Weight : 
Degam: 
 
2. Description of the suspected Adverse Reactions (please complete boxes below) 
Date and time  of 
initial observation 
 Season: 
Description of 
reaction   
 Geographical area: 
 
3. List of all medicines / Formulations including drugs of other systems used by the 
patient during the reporting period: 
Medicine Daily 
dose 
Route of 
administration 
& Vehicle - 
Adjuvant 
Date  Diagnosis for 
which medicine 
taken  
Starting Stopped 
Siddha      
Any other 
system of 
medicines 
     
 
 
Reporting Form for Suspected Adverse Reactions to Siddha 
Drugs 
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4. Brief details of the Siddha Medicine which seems to be toxic : 
Details Drug – 1 Drug – 2 Drug – 3 
a) Name of the medicine    
b) Manufacturing unit 
and batch No. and date 
   
c) Expiry date    
d) Purchased and 
obtained from 
   
e) Composition of the 
formulation / Part of the 
drug used 
   
 
b) Dietary Restrictions if any 
c) Whether the drug is consumed under Institutionally qualified medical supervision or 
used as self medication.  
d) Any other relevant information. 
5. Treatment provided for adverse reaction: 
6. The result  of the adverse reaction / side effect / untoward effects (please complete 
the boxes below) 
Recovered:           Not 
recovered: 
 Unknown: Fatal: If Fatal 
Date of death: 
Severe:   Yes   /   
No. 
Reaction abated after drug stopped or dose reduced: 
Reaction reappeared after re introduction: 
 
 
Was the patient admitted to hospital? 
If yes, give name and address of 
hospital 
 
 
7. Any laboratory investigations done to evaluate other possibilities?  If Yes specify:  
8. Whether the patient is suffering with any chronic disorders? 
Hepatic    Renal    Cardiac    Diabetes    Malnutrition  
Any Others  
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9. H/O previous allergies / Drug reactions:  
10. Other illness (please describe): 
11. Identification of the reporter: 
 
Type (please tick):  Nurse / Doctor / Pharmacist / Health worker / Patient / 
Attendant / Manufacturer / Distributor / Supplier / Any others (please specify) 
Name: 
Address: 
Telephone / E – mail if any : 
 
Signature of the reporter:     Date: 
Please send the completed form to:  
    The Director 
    National Institute of Siddha, 
(Pharmacovigilance Regional Centre For Siddha 
Medicine), 
    Tambaram Sanatorium, Chennai-600 047. 
 (O) 044-22381314 Fax : 044 – 22381314 
Website : www.nischennai.org 
Email: nischennaisiddha@yahoo.co.in 
 
* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * *  
This filled-in ADR report may be sent within one month of observation /occurrence 
of ADR   
 
 
 
 
 
 
Date:                                                                              
Station:  
Signature of the Investigator: 
Signature of the Lecturer:                                                  Signature of the HOD  
  
Who Can Report? 
 Any Health care professionals like Siddha Doctors /  
Nurses / Siddha Pharmacists / Patients etc.  
What to Report?  
 All reactions,  Drug interactions,  
Confidentiality  
 The patient’s identity will be held in strict confidence 
and protected to the fullest extent.  
 Submission of report will be taken up for remedial 
measures only not for legal claim  
Name & address of 
theRRC-ASU/ PPC-ASU 
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NATIONAL INSTITUTE OF SIDDHA 
AYOTHIDOSS PANDITHAR HOSPITAL, CHENNAI – 600 047. 
 
COMPARATIVE CLINICAL STUDY OF SIDDHA DRUG “VITHU RASA MEZHUGU” 
(INTERNAL) AND “MURIVU ENNAI” (EXTERNAL) IN THE TREATMENT OF 
MUZHANGAL MOOTU SAVVU KAYANGAL(LIGAMENT INJURY-KNEE JOINT). 
 
Principal Investigator: Dr.M.Monika 
 
FORM - VII DIETARY ADVICE FORM 
 
§º÷ì¸ ÜÊÂ ¯½×¸û ¾Å¢÷ì¸ §ÅñÊÂ¨Å¸û 
 
¸¡ö¸û (Vegetables): 
¸ò¾Ã¢ôÀ¢ïÍ (Unripe brinjal) 
ÓÕí¨¸ôÀ¢ïÍ (Unripe drumstick) 
«Å¨ÃôÀ¢ïÍ (Unripe Dolichos bean) 
¸£¨Ã¸û(Greens): 
¦À¡ýÉ¡í¸ñ½¢ (Sessile plant 
[Alternanthera sessilis] ) 
ãì¸¢Ãð¨¼ (Hog weed [Boerhaavia diffusa] ) 
àÐ§Å¨Ç (Climbing brinjal [Solanum 
trilobatum] ) 
ÓÕí¨¸ì¸£¨Ã (Leaves of Drumstick 
[Moringa oleifera] ) 
¸È¢§ÅôÀ¢¨Ä (Curry leaf [Murraya koenigii] ) 
Ó¼ì¸Úò¾¡ý (Winter cherry [Cardiospermum 
halicacabum] ) 
«Ú¸£¨Ã (Amaranthus tristis) 
¸Ã¢º¡¨Ä (trailing eclipta [Eclipta prostrate] ) 
ÀÆí¸û(Fruits): 
Á¡Ð¨Ç (Pomegranate) 
¬ôÀ¢û (Apple) 
ÀôÀ¡Ç¢ (Papaya) 
¬ÃïÍ (Orange) 
§ÀÃ£î¨º (Dates) 
«ò¾¢ (Fig) 
¿¡Åø (Jambul [Syzygium cumini] ) «¨ºÅõ 
(Non-vegetarian diet): 
¦ÅûÇ¡ðÎì¸È¢ (Meat)  
¸¡¨¼ (Quail) , º¢Ú þÈ¡øÁ£ý (Prawn) 
 
Í¨Ã (Bottle gourd) 
âº½¢ (Pumpkin) 
¦ÅûÇÃ¢ì¸¡ö (Cucumber) 
Ò¼¨Ä (Snake gourd) 
À£÷ìÌ (Ridged gourd) 
¯ÙóÐ (Black gram) 
¦Á¡î¨º (Indian butter Bean) 
¸¡Ã¡Á½¢ (Cow gram) 
¦¸¡ûÙ (Horse gram) 
¸ÎÌ (Mustard) 
±ñ¦½ö (Gingelly oil) 
ÒÇ¢ôÒ (Sour) 
¯ôÒ (Salt) 
Å¡Ôô ¦À¡Õð¸û (Vatha diet) 
¯Õ¨Çì ¸¢ÆíÌ (Potato) 
Å¡¨Æì ¸¡ö (Plantain) 
Ò¨¸Â¢¨Ä (Tobacco) 
ÁÐ «ÕóÐ¾ø (Alcohol) 
¦Àñ§À¡¸õ (þîº¡ Àò¾¢Âõ) [Sexual 
intercourse] 
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